{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:25Z","timestamp":1790638645321,"version":"4.1.0"},"publisher-location":"Cham","reference-count":258,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031329968","type":"print"},{"value":"9783031329975","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-32997-5_3","type":"book-chapter","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T14:01:38Z","timestamp":1690034498000},"page":"97-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson\u2019s Disease Following Concussive Head Injury"],"prefix":"10.1007","author":[{"given":"Lianyuan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafin F.","family":"Muresanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Ryan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Vicente","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca D.","family":"Buzoianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Nozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari Shanker","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,23]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","unstructured":"The Lancet Neurology. Parkinson\u2019s disease needs an urgent public health response. Lancet Neurol. 2022;21(9):759. https:\/\/doi.org\/10.1016\/S1474-4422(22)00312-X.","DOI":"10.1016\/S1474-4422(22)00312-X"},{"issue":"7 Suppl 1","key":"3_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0000000000200789","volume":"99","author":"GF Crotty","year":"2022","unstructured":"Crotty GF, Keavney JL, Alcalay RN, Marek K, Marshall GA, Rosas HD, Schwarzschild MA. Planning for prevention of Parkinson disease: now is the time. Neurology. 2022;99(7 Suppl 1):1\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000200789.","journal-title":"Neurology"},{"issue":"7","key":"3_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mds.29037","volume":"37","author":"X Zhou","year":"2022","unstructured":"Zhou X, Liu Z, Zhou X, Xiang Y, Zhou Z, Zhao Y, Pan H, Xu Q, Chen Y, Sun Q, Wu X, Tan H, Li B, Yuan K, Xie Y, Liao W, Hu S, Zhu J, Wu X, Li J, Wang C, Lei L, Tang J, Liu Y, Wu H, Huang W, Wang T, Xue Z, Wang P, Zhang Z, Xu P, Chen L, Wang Q, Wang X, Cheng O, Shen Y, Liu W, Ye M, You Y, Li J, Yan X, Guo J, Tang B, for Parkinson\u2019s Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD-MDCNC). The Chinese Parkinson\u2019s Disease Registry (CPDR): study design and baseline patient characteristics. Mov Disord. 2022;37(7):1335\u201345. https:\/\/doi.org\/10.1002\/mds.29037. Epub 2022 May 3","journal-title":"Mov Disord"},{"issue":"1","key":"3_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.pbr.2022.01.004","volume":"269","author":"MA Bock","year":"2022","unstructured":"Bock MA, Tanner CM. The epidemiology of cognitive function in Parkinson\u2019s disease. Prog Brain Res. 2022;269(1):3\u201337. https:\/\/doi.org\/10.1016\/bs.pbr.2022.01.004. Epub 2022 Feb 4","journal-title":"Prog Brain Res"},{"issue":"6","key":"3_CR5","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1007\/s10072-021-05854-3","volume":"43","author":"M Ulivelli","year":"2022","unstructured":"Ulivelli M, Bezzini D, Kundisova L, Grazi I, Battaglia MA, Nante N, Rossi S. Mortality of Parkinson\u2019s disease in Italy from 1980 to 2015. Neurol Sci. 2022;43(6):3603\u201311. https:\/\/doi.org\/10.1007\/s10072-021-05854-3. Epub 2022 Jan 30","journal-title":"Neurol Sci"},{"issue":"Suppl 1","key":"3_CR6","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF. Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;22(Suppl 1):S119\u201322. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004. Epub 2015 Sep 3","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"3_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S. The clinical symptoms of Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):318\u201324. https:\/\/doi.org\/10.1111\/jnc.13691. Epub 2016 Jul 11","journal-title":"J Neurochem"},{"issue":"5","key":"3_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X. Epub 2019 Mar 14","journal-title":"Lancet Neurol"},{"issue":"1","key":"3_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00207454.2018.1486837","volume":"129","author":"AU Khan","year":"2019","unstructured":"Khan AU, Akram M, Daniyal M, Zainab R. Awareness and current knowledge of Parkinson\u2019s disease: a neurodegenerative disorder. Int J Neurosci. 2019;129(1):55\u201393. https:\/\/doi.org\/10.1080\/00207454.2018.1486837. Epub 2018 Nov 22","journal-title":"Int J Neurosci"},{"issue":"5","key":"3_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1871527317666180612125843","volume":"17","author":"S Wang","year":"2018","unstructured":"Wang S, Ma F, Huang L, Zhang Y, Peng Y, Xing C, Feng Y, Wang X, Peng Y. Dl-3-n-butylphthalide (NBP): a promising therapeutic agent for ischemic stroke. CNS Neurol Disord Drug Targets. 2018;17(5):338\u201347. https:\/\/doi.org\/10.2174\/1871527317666180612125843.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3389\/fphar.2019.01595","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Shen Y, Liu Z, Gu J, Xu C, Qian S, Zhang X, Zhou B, Jin Y, Sun Y. Dl-NBP (Dl-3-N-butylphthalide) treatment promotes neurological functional recovery accompanied by the upregulation of white matter integrity and HIF-1\u03b1\/VEGF\/notch\/Dll4 expression. Front Pharmacol. 2020;10:1595. https:\/\/doi.org\/10.3389\/fphar.2019.01595. eCollection 2019","journal-title":"Front Pharmacol"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbr.2017.04.039","volume":"329","author":"Y Sun","year":"2017","unstructured":"Sun Y, Cheng X, Wang H, Mu X, Liang Y, Luo Y, Qu H, Zhao C. dl-3-n-butylphthalide promotes neuroplasticity and motor recovery in stroke rats. Behav Brain Res. 2017;329:67\u201374. https:\/\/doi.org\/10.1016\/j.bbr.2017.04.039. Epub 2017 Apr 22","journal-title":"Behav Brain Res"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/bs.pbr.2020.09.011","volume":"258","author":"F Niu","year":"2020","unstructured":"Niu F, Sharma A, Wang Z, Feng L, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Patnaik R, Wiklund L, Sharma HS. Co-administration of TiO2-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced neuroprotection in Parkinson\u2019s disease exacerbated by concussive head injury. Prog Brain Res. 2020;258:101\u201355. https:\/\/doi.org\/10.1016\/bs.pbr.2020.09.011. Epub 2020 Nov 9","journal-title":"Prog Brain Res"},{"issue":"1","key":"3_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12035-017-0746-5","volume":"55","author":"L Feng","year":"2018","unstructured":"Feng L, Sharma A, Niu F, Huang Y, Lafuente JV, Muresanu DF, Ozkizilcik A, Tian ZR, Sharma HS. TiO2-Nanowired delivery of DL-3-n-butylphthalide (DL-NBP) attenuates blood-brain barrier disruption, brain Edema formation, and neuronal damages following concussive head injury. Mol Neurobiol. 2018;55(1):350\u20138. https:\/\/doi.org\/10.1007\/s12035-017-0746-5.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/jcmm.14691","volume":"24","author":"F Wu","year":"2020","unstructured":"Wu F, Xu K, Xu K, Teng C, Zhang M, Xia L, Zhang K, Liu L, Chen Z, Xiao J, Wu Y, Zhang H, Chen D. Dl-3n-butylphthalide improves traumatic brain injury recovery via inhibiting autophagy-induced blood-brain barrier disruption and cell apoptosis. J Cell Mol Med. 2020;24(2):1220\u201332. https:\/\/doi.org\/10.1111\/jcmm.14691. Epub 2019 Dec 16","journal-title":"J Cell Mol Med"},{"issue":"20","key":"3_CR16","doi-asserted-by":"publisher","first-page":"e1771","DOI":"10.1212\/WNL.0000000000005522","volume":"90","author":"RC Gardner","year":"2018","unstructured":"Gardner RC, Byers AL, Barnes DE, Li Y, Boscardin J, Yaffe K. Mild TBI and risk of Parkinson disease: a chronic effects of neurotrauma consortium study. Neurology. 2018;90(20):e1771\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000005522. Epub 2018 Apr 18","journal-title":"Neurology"},{"issue":"3 Suppl","key":"3_CR17","doi-asserted-by":"publisher","first-page":"S226","DOI":"10.1016\/j.jalz.2014.04.005","volume":"10","author":"MW Weiner","year":"2014","unstructured":"Weiner MW, Veitch DP, Hayes J, Neylan T, Grafman J, Aisen PS, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Shaw LM, Saykin AJ, Green RC, Harvey D, Toga AW, Friedl KE, Pacifico A, Sheline Y, Yaffe K, Mohlenoff B, Department of Defense Alzheimer\u2019s Disease Neuroimaging Initiative. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer\u2019s disease in veterans, using the Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimers Dement. 2014;10(3 Suppl):S226\u201335. https:\/\/doi.org\/10.1016\/j.jalz.2014.04.005.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"3_CR18","doi-asserted-by":"publisher","first-page":"166953","DOI":"10.1016\/j.jmb.2021.166953","volume":"433","author":"S Dhakal","year":"2021","unstructured":"Dhakal S, Wyant CE, George HE, Morgan SE, Rangachari V. Prion-like C-terminal domain of TDP-43 and \u03b1-synuclein interact synergistically to generate neurotoxic hybrid fibrils. J Mol Biol. 2021;433(10):166953. https:\/\/doi.org\/10.1016\/j.jmb.2021.166953. Epub 2021 Mar 24","journal-title":"J Mol Biol"},{"issue":"12","key":"3_CR19","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3390\/cells10123389","volume":"10","author":"K Gaweda-Walerych","year":"2021","unstructured":"Gaweda-Walerych K, Sitek EJ, Naro\u017ca\u0144ska E, Buratti E. Parkin beyond Parkinson\u2019s disease-a functional meaning of parkin downregulation in TDP-43 proteinopathies. Cell. 2021;10(12):3389. https:\/\/doi.org\/10.3390\/cells10123389.","journal-title":"Cell"},{"key":"3_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67587","volume":"10","author":"EN Anderson","year":"2021","unstructured":"Anderson EN, Morera AA, Kour S, Cherry JD, Ramesh N, Gleixner A, Schwartz JC, Ebmeier C, Old W, Donnelly CJ, Cheng JP, Kline AE, Kofler J, Stein TD, Pandey UB. Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology. elife. 2021;10:e67587. https:\/\/doi.org\/10.7554\/eLife.67587.","journal-title":"elife"},{"issue":"8","key":"3_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1212\/WNL.0000000000008991","volume":"94","author":"EG Brown","year":"2020","unstructured":"Brown EG, Goldman SM. Traumatic brain injury and \u03b1-synuclein: proceed with caution. Neurology. 2020;94(8):335\u20136. https:\/\/doi.org\/10.1212\/WNL.0000000000008991. Epub 2020 Jan 28","journal-title":"Neurology"},{"issue":"6402","key":"3_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0140-6736(46)91585-1","volume":"1","author":"E Teller","year":"1946","unstructured":"Teller E. Paralysis agitans. Lancet. 1946;1(6402):717. https:\/\/doi.org\/10.1016\/s0140-6736(46)91585-1.","journal-title":"Lancet"},{"issue":"1","key":"3_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mds.870050112","volume":"5","author":"BV Manyam","year":"1990","unstructured":"Manyam BV. Paralysis agitans and levodopa in \u201cAyurveda\u201d: ancient Indian medical treatise. Mov Disord. 1990;5(1):47\u20138. https:\/\/doi.org\/10.1002\/mds.870050112.","journal-title":"Mov Disord"},{"issue":"2","key":"3_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223\u201336; discussion 222","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.parkreldis.2019.06.001","volume":"65","author":"R Mehanna","year":"2019","unstructured":"Mehanna R, Jankovic J. Young-onset Parkinson\u2019s disease: its unique features and their impact on quality of life. Parkinsonism Relat Disord. 2019;65:39\u201348. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.001. Epub 2019 Jun 1","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"3_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41591-019-0739-1","volume":"26","author":"AH Laperle","year":"2020","unstructured":"Laperle AH, Sances S, Yucer N, Dardov VJ, Garcia VJ, Ho R, Fulton AN, Jones MR, Roxas KM, Avalos P, West D, Banuelos MG, Shu Z, Murali R, Maidment NT, Van Eyk JE, Tagliati M, Svendsen CN. iPSC modeling of young-onset Parkinson\u2019s disease reveals a molecular signature of disease and novel therapeutic candidates. Nat Med. 2020;26(2):289\u201399. https:\/\/doi.org\/10.1038\/s41591-019-0739-1. Epub 2020 Jan 27","journal-title":"Nat Med"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/bs.pbr.2019.03.014","volume":"245","author":"A Ozkizilcik","year":"2019","unstructured":"Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, M\u00f6ssler H, Sharma HS. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson\u2019s disease. Prog Brain Res. 2019;245:201\u201346. https:\/\/doi.org\/10.1016\/bs.pbr.2019.03.014. Epub 2019 Apr 2","journal-title":"Prog Brain Res"},{"issue":"4","key":"3_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","volume":"75","author":"GF Wooten","year":"2004","unstructured":"Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson\u2019s disease than women? J Neurol Neurosurg Psychiatry. 2004;75(4):637\u20139. https:\/\/doi.org\/10.1136\/jnnp.2003.020982.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"3_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2174\/1389557519666191104110908","volume":"20","author":"BLB Marino","year":"2020","unstructured":"Marino BLB, de Souza LR, Sousa KPA, Ferreira JV, Padilha EC, da Silva CHTP, Taft CA, Hage-Melim LIS. Parkinson\u2019s disease: a review from pathophysiology to treatment. Mini Rev Med Chem. 2020;20(9):754\u201367. https:\/\/doi.org\/10.2174\/1389557519666191104110908.","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"3_CR30","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/brain\/awaa019","volume":"143","author":"MC Ruppert","year":"2020","unstructured":"Ruppert MC, Greuel A, Tahmasian M, Schwartz F, St\u00fcrmer S, Maier F, Hammes J, Tittgemeyer M, Timmermann L, van Eimeren T, Drzezga A, Eggers C. Network degeneration in Parkinson\u2019s disease: multimodal imaging of nigro-striato-cortical dysfunction. Brain. 2020;143(3):944\u201359. https:\/\/doi.org\/10.1093\/brain\/awaa019.","journal-title":"Brain"},{"issue":"2","key":"3_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol. 2013;47(2):495\u2013508. https:\/\/doi.org\/10.1007\/s12035-012-8280-y. Epub 2012 May 24","journal-title":"Mol Neurobiol"},{"issue":"10","key":"3_CR32","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK. \u03b1-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteom. 2019;1867(10):890\u2013908. https:\/\/doi.org\/10.1016\/j.bbapap.2019.03.001. Epub 2019 Mar 7","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"issue":"6645","key":"3_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839\u201340. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"issue":"5","key":"3_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"issue":"23","key":"3_CR35","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.neuron.2021.09.031","volume":"109","author":"BA Seo","year":"2021","unstructured":"Seo BA, Kim D, Hwang H, Kim MS, Ma SX, Kwon SH, Kweon SH, Wang H, Yoo JM, Choi S, Kwon SH, Kang SU, Kam TI, Kim K, Karuppagounder SS, Kang BG, Lee S, Park H, Kim S, Yan W, Li YS, Kuo SH, Redding-Ochoa J, Pletnikova O, Troncoso JC, Lee G, Mao X, Dawson VL, Dawson TM, Ko HS. TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson\u2019s disease. Neuron. 2021;109(23):3758\u20133774.e11. https:\/\/doi.org\/10.1016\/j.neuron.2021.09.031. Epub 2021 Oct 12","journal-title":"Neuron"},{"issue":"6","key":"3_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.14670\/HH-18-073","volume":"34","author":"L Cuenca","year":"2019","unstructured":"Cuenca L, Gil-Martinez AL, Cano-Fernandez L, Sanchez-Rodrigo C, Estrada C, Fernandez-Villalba E, Herrero MT. Parkinson\u2019s disease: a short story of 200 years. Histol Histopathol. 2019;34(6):573\u201391. https:\/\/doi.org\/10.14670\/HH-18-073. Epub 2018 Dec 12","journal-title":"Histol Histopathol"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fphar.2020.00435","volume":"11","author":"E Paredes-Rodriguez","year":"2020","unstructured":"Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C. The noradrenergic system in Parkinson\u2019s disease. Front Pharmacol. 2020;11:435. https:\/\/doi.org\/10.3389\/fphar.2020.00435. eCollection 2020","journal-title":"Front Pharmacol"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnagi.2016.00196","volume":"8","author":"IU Isaias","year":"2016","unstructured":"Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A. Neuromelanin imaging and dopaminergic loss in Parkinson\u2019s disease. Front Aging Neurosci. 2016;8:196. https:\/\/doi.org\/10.3389\/fnagi.2016.00196. eCollection 2016","journal-title":"Front Aging Neurosci"},{"key":"3_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/543673","volume":"2014","author":"BR Corradini","year":"2014","unstructured":"Corradini BR, Iamashita P, Tampellini E, Farfel JM, Grinberg LT, Moreira-Filho CA. Complex network-driven view of genomic mechanisms underlying Parkinson\u2019s disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra. Biomed Res Int. 2014;2014:543673. https:\/\/doi.org\/10.1155\/2014\/543673. Epub 2014 Nov 26","journal-title":"Biomed Res Int"},{"issue":"1","key":"3_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-202279","volume":"11","author":"RJ Smeyne","year":"2021","unstructured":"Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Infection and risk of Parkinson\u2019s disease. J Parkinsons Dis. 2021;11(1):31\u201343. https:\/\/doi.org\/10.3233\/JPD-202279.","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"3_CR41","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s10072-017-3077-4","volume":"38","author":"AI Abushouk","year":"2017","unstructured":"Abushouk AI, El-Husseny MWA, Magdy M, Ismail A, Attia A, Ahmed H, Pallanti R, Negida A. Evidence for association between hepatitis C virus and Parkinson\u2019s disease. Neurol Sci. 2017;38(11):1913\u201320. https:\/\/doi.org\/10.1007\/s10072-017-3077-4. Epub 2017 Aug 5","journal-title":"Neurol Sci"},{"key":"3_CR42","doi-asserted-by":"publisher","unstructured":"Olubodun-Obadun TG, Ishola IO, Adeyemi OO. Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease. Drug Metab Pers Ther. 2022; https:\/\/doi.org\/10.1515\/dmpt-2021-0144. Online ahead of print","DOI":"10.1515\/dmpt-2021-0144"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"708587","DOI":"10.3389\/fnins.2021.708587","volume":"15","author":"AE Hill","year":"2021","unstructured":"Hill AE, Wade-Martins R, Burnet PWJ. What is our understanding of the influence of gut microbiota on the pathophysiology of Parkinson\u2019s disease? Front Neurosci. 2021;15:708587. https:\/\/doi.org\/10.3389\/fnins.2021.708587. eCollection 2021","journal-title":"Front Neurosci"},{"issue":"1","key":"3_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13(1):21. https:\/\/doi.org\/10.1186\/s13024-018-0257-5.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"3_CR45","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s11011-021-00808-2","volume":"36","author":"SA Moustafa","year":"2021","unstructured":"Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson\u2019s disease. Metab Brain Dis. 2021;36(7):1545\u201357. https:\/\/doi.org\/10.1007\/s11011-021-00808-2. Epub 2021 Aug 9","journal-title":"Metab Brain Dis"},{"issue":"4","key":"3_CR46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368\u201376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"s1","key":"3_CR47","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.3233\/JPD-202036","volume":"10","author":"A Fanciulli","year":"2020","unstructured":"Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK. Management of Orthostatic Hypotension in Parkinson\u2019s disease. J Parkinsons Dis. 2020;10(s1):S57\u201364. https:\/\/doi.org\/10.3233\/JPD-202036.","journal-title":"J Parkinsons Dis"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.09.024","volume":"45","author":"KA Schindlbeck","year":"2017","unstructured":"Schindlbeck KA, Sch\u00f6nfeld S, Naumann W, Friedrich DJ, Maier A, Rewitzer C, Klostermann F, Marzinzik F. Characterization of diplopia in non-demented patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;45:1\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.09.024. Epub 2017 Sep 29","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"3_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2217\/nmt-2018-0021","volume":"8","author":"K Dashtipour","year":"2018","unstructured":"Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson\u2019s disease: pathophysiology, medical management and surgical approaches. Neurodegener Dis Manag. 2018;8(5):337\u201348. https:\/\/doi.org\/10.2217\/nmt-2018-0021. Epub 2018 Sep 18","journal-title":"Neurodegener Dis Manag"},{"issue":"11","key":"3_CR50","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.27460","volume":"33","author":"L Ramig","year":"2018","unstructured":"Ramig L, Halpern A, Spielman J, Fox C, Freeman K. Speech treatment in Parkinson\u2019s disease: randomized controlled trial (RCT). Mov Disord. 2018;33(11):1777\u201391. https:\/\/doi.org\/10.1002\/mds.27460. Epub 2018 Sep 28","journal-title":"Mov Disord"},{"issue":"2","key":"3_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, the collaborators of the Parkinson\u2019s Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180\u201398. https:\/\/doi.org\/10.1002\/mds.27602. Epub 2019 Jan 17","journal-title":"Mov Disord"},{"issue":"1","key":"3_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41386-019-0448-y","volume":"45","author":"A Stefani","year":"2020","unstructured":"Stefani A, H\u00f6gl B. Sleep in Parkinson\u2019s disease. Neuropsychopharmacology. 2020;45(1):121\u20138. https:\/\/doi.org\/10.1038\/s41386-019-0448-y. Epub 2019 Jun 24","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"3_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12673","volume":"27","author":"S Mantovani","year":"2018","unstructured":"Mantovani S, Smith SS, Gordon R, O\u2019Sullivan JD. An overview of sleep and circadian dysfunction in Parkinson\u2019s disease. J Sleep Res. 2018;27(3):e12673. https:\/\/doi.org\/10.1111\/jsr.12673. Epub 2018 Mar 1","journal-title":"J Sleep Res"},{"issue":"2","key":"3_CR54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1055\/s-0039-1678579","volume":"39","author":"M Sezgin","year":"2019","unstructured":"Sezgin M, Bilgic B, Tinaz S, Emre M. Parkinson\u2019s disease dementia and Lewy body disease. Semin Neurol. 2019;39(2):274\u201382. https:\/\/doi.org\/10.1055\/s-0039-1678579. Epub 2019 Mar 2","journal-title":"Semin Neurol"},{"issue":"4","key":"3_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13(4):217\u201331. https:\/\/doi.org\/10.1038\/nrneurol.2017.27. Epub 2017 Mar 3","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"3_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"M Delgado-Alvarado","year":"2016","unstructured":"Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jim\u00e9nez-Urbieta H, Rodriguez-Oroz MC. Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2016;31(6):861\u201381. https:\/\/doi.org\/10.1002\/mds.26662. Epub 2016 May 19","journal-title":"Mov Disord"},{"issue":"12","key":"3_CR57","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7. Epub 2016 Oct 11","journal-title":"Lancet Neurol"},{"issue":"1","key":"3_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ana.25726","volume":"88","author":"DL White","year":"2020","unstructured":"White DL, Kunik ME, Yu H, Lin HL, Richardson PA, Moore S, Sarwar AI, Marsh L, Jorge RE. Post-traumatic stress disorder is associated with further increased Parkinson\u2019s disease risk in veterans with traumatic brain injury. Ann Neurol. 2020;88(1):33\u201341. https:\/\/doi.org\/10.1002\/ana.25726. Epub 2020 Apr 29","journal-title":"Ann Neurol"},{"issue":"5","key":"3_CR59","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","volume":"91","author":"BL Brett","year":"2022","unstructured":"Brett BL, Gardner RC, Godbout J, Dams-O\u2019Connor K, Keene CD. Traumatic brain injury and risk of neurodegenerative disorder. Biol Psychiatry. 2022;91(5):498\u2013507. https:\/\/doi.org\/10.1016\/j.biopsych.2021.05.025. Epub 2021 Jun 2","journal-title":"Biol Psychiatry"},{"issue":"1","key":"3_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40779-021-00363-y","volume":"9","author":"LZ Kong","year":"2022","unstructured":"Kong LZ, Zhang RL, Hu SH, Lai JB. Military traumatic brain injury: a challenge straddling neurology and psychiatry. Mil Med Res. 2022;9(1):2. https:\/\/doi.org\/10.1186\/s40779-021-00363-y.","journal-title":"Mil Med Res"},{"issue":"17\u201318","key":"3_CR61","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1089\/neu.2022.0103","volume":"39","author":"MA Lindberg","year":"2022","unstructured":"Lindberg MA, Moy Martin EM, Marion DW. Military traumatic brain injury: the history, impact, and future. J Neurotrauma. 2022;39(17\u201318):1133\u201345. https:\/\/doi.org\/10.1089\/neu.2022.0103. Epub 2022 Jun 3","journal-title":"J Neurotrauma"},{"issue":"1","key":"3_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40779-021-00334-3","volume":"8","author":"SF Hussain","year":"2021","unstructured":"Hussain SF, Raza Z, Cash ATG, Zampieri T, Mazzoli RA, Kardon RH, Gomes RSM. Traumatic brain injury and sight loss in military and veteran populations- a review. Mil Med Res. 2021;8(1):42. https:\/\/doi.org\/10.1186\/s40779-021-00334-3.","journal-title":"Mil Med Res"},{"issue":"12","key":"3_CR63","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41582-018-0091-y","volume":"14","author":"T Mollayeva","year":"2018","unstructured":"Mollayeva T, Mollayeva S, Colantonio A. Traumatic brain injury: sex, gender and intersecting vulnerabilities. Nat Rev Neurol. 2018;14(12):711\u201322. https:\/\/doi.org\/10.1038\/s41582-018-0091-y.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"3_CR64","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/mds.25891","volume":"29","author":"C Marras","year":"2014","unstructured":"Marras C, Saunders-Pullman R. The complexities of hormonal influences and risk of Parkinson\u2019s disease. Mov Disord. 2014;29(7):845\u20138. https:\/\/doi.org\/10.1002\/mds.25891. Epub 2014 Apr 30","journal-title":"Mov Disord"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1196\/annals.1386.004","volume":"1089","author":"P Ragonese","year":"2006","unstructured":"Ragonese P, D\u2019Amelio M, Savettieri G. Implications for estrogens in Parkinson\u2019s disease: an epidemiological approach. Ann N Y Acad Sci. 2006;1089:373\u201382. https:\/\/doi.org\/10.1196\/annals.1386.004.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"3_CR66","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/brainsci11081027","volume":"11","author":"D Santos Garc\u00eda","year":"2021","unstructured":"Santos Garc\u00eda D, Bl\u00e1zquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, Garc\u00eda Ruiz PJ, Grandas F, Kulisevsky J, L\u00f3pez-Manzanares L, Mart\u00ednez Castrillo JC, Mir P, Pagonabarraga J, P\u00e9rez-Errazquin F, Salom JM, Tijero B, Valldeoriola F, Y\u00e1\u00f1ez R, Avil\u00e9s A, Luqu\u00edn MR. Present and future of Parkinson\u2019s disease in Spain: PARKINSON-2030 Delphi project. Brain Sci. 2021;11(8):1027. https:\/\/doi.org\/10.3390\/brainsci11081027.","journal-title":"Brain Sci"},{"issue":"5","key":"3_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000247740.47667.03. Epub 2006 Nov 2","journal-title":"Neurology"},{"issue":"4","key":"3_CR68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/traumacare2040042","volume":"2","author":"WS Dodd","year":"2022","unstructured":"Dodd WS, Panther EJ, Pierre K, Hernandez JS, Patel D, Lucke-Wold B. Traumatic brain injury and secondary neurodegenerative disease. Trauma Care (Basel). 2022;2(4):510\u201322. https:\/\/doi.org\/10.3390\/traumacare2040042. Epub 2022 Sep 26","journal-title":"Trauma Care (Basel)"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40035-017-0088-2","volume":"6","author":"M Cruz-Haces","year":"2017","unstructured":"Cruz-Haces M, Tang J, Acosta G, Fernandez J, Shi R. Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl Neurodegener. 2017;6:20. https:\/\/doi.org\/10.1186\/s40035-017-0088-2. eCollection 2017","journal-title":"Transl Neurodegener"},{"issue":"4","key":"3_CR70","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000515393","volume":"55","author":"GBD 2019 Dementia Collaborators","year":"2021","unstructured":"GBD 2019 Dementia Collaborators. The burden of dementia due to down syndrome, Parkinson\u2019s disease, stroke, and traumatic brain injury: a systematic analysis for the global burden of disease study 2019. Neuroepidemiology. 2021;55(4):286\u201396. https:\/\/doi.org\/10.1159\/000515393. Epub 2021 Jun 28","journal-title":"Neuroepidemiology"},{"key":"3_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105080","volume":"145","author":"EA van Vliet","year":"2020","unstructured":"van Vliet EA, Ndode-Ekane XE, Lehto LJ, Gorter JA, Andrade P, Aronica E, Gr\u00f6hn O, Pitk\u00e4nen A. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury. Neurobiol Dis. 2020;145:105080. https:\/\/doi.org\/10.1016\/j.nbd.2020.105080. Epub 2020 Sep 9","journal-title":"Neurobiol Dis"},{"key":"3_CR72","doi-asserted-by":"publisher","first-page":"855701","DOI":"10.3389\/fimmu.2022.855701","volume":"13","author":"RZ Zheng","year":"2022","unstructured":"Zheng RZ, Lee KY, Qi ZX, Wang Z, Xu ZY, Wu XH, Mao Y. Neuroinflammation following traumatic brain injury: take it seriously or not. Front Immunol. 2022;13:855701. https:\/\/doi.org\/10.3389\/fimmu.2022.855701. eCollection 2022","journal-title":"Front Immunol"},{"issue":"11","key":"3_CR73","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373. https:\/\/doi.org\/10.1038\/s41577-022-00684-6. Epub 2022 Mar 4","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3_CR74","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G, Sharp DJ. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374\u201383. https:\/\/doi.org\/10.1002\/ana.22455. Epub 2011 Jun 27","journal-title":"Ann Neurol"},{"issue":"1","key":"3_CR75","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/1673-5374.314285","volume":"17","author":"CX Huang","year":"2022","unstructured":"Huang CX, Li YH, Lu W, Huang SH, Li MJ, Xiao LZ. Positron emission tomography imaging for the assessment of mild traumatic brain injury and chronic traumatic encephalopathy: recent advances in radiotracers. Liu J Neural Regen Res. 2022;17(1):74\u201381. https:\/\/doi.org\/10.4103\/1673-5374.314285.","journal-title":"Liu J Neural Regen Res"},{"issue":"Pt 9","key":"3_CR76","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/brain\/awp148","volume":"132","author":"S Rosi","year":"2009","unstructured":"Rosi S, Ramirez-Amaya V, Vazdarjanova A, Esparza EE, Larkin PB, Fike JR, Wenk GL, Barnes CA. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain. 2009;132(Pt 9):2464\u201377. https:\/\/doi.org\/10.1093\/brain\/awp148. Epub 2009 Jun 16","journal-title":"Brain"},{"key":"3_CR77","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainresbull.2021.08.013","volume":"176","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhao WJ, Quan W, Qiao CM, Cui C, Hong H, Shi Y, Niu GY, Zhao LP, Shen YQ. Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson\u2019s disease mouse model. Brain Res Bull. 2021;176:174\u201383. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.08.013. Epub 2021 Sep 1","journal-title":"Brain Res Bull"},{"issue":"15","key":"3_CR78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118819119","volume":"119","author":"JT Hinkle","year":"2022","unstructured":"Hinkle JT, Patel J, Panicker N, Karuppagounder SS, Biswas D, Belingon B, Chen R, Brahmachari S, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM. STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy. Proc Natl Acad Sci U S A. 2022;119(15):e2118819119. https:\/\/doi.org\/10.1073\/pnas.2118819119. Epub 2022 Apr 8","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR79","doi-asserted-by":"publisher","first-page":"719807","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, Xiong N, Wang T. Targeting microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s disease. Front Immunol. 2021;12:719807. https:\/\/doi.org\/10.3389\/fimmu.2021.719807. eCollection 2021","journal-title":"Front Immunol"},{"issue":"1","key":"3_CR80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09540261.2019.1656177","volume":"32","author":"JM Joyce","year":"2020","unstructured":"Joyce JM, Monchi O, Ismail Z, Kibreab M, Cheetham J, Kathol I, Sarna J, Martino D, Debert CT. The impact of traumatic brain injury on cognitive and neuropsychiatric symptoms of Parkinson\u2019s disease. Int Rev Psychiatry. 2020;32(1):46\u201360. https:\/\/doi.org\/10.1080\/09540261.2019.1656177. Epub 2019 Oct 21","journal-title":"Int Rev Psychiatry"},{"key":"3_CR81","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnagi.2020.00080","volume":"12","author":"MT Uemura","year":"2020","unstructured":"Uemura MT, Maki T, Ihara M, Lee VMY, Trojanowski JQ. Brain microvascular pericytes in vascular cognitive impairment and dementia. Front Aging Neurosci. 2020;12:80. https:\/\/doi.org\/10.3389\/fnagi.2020.00080. eCollection 2020","journal-title":"Front Aging Neurosci"},{"key":"3_CR82","first-page":"1","volume-title":"The blood-spinal cord and brain barriers in health and disease","author":"HS Sharma","year":"2004","unstructured":"Sharma HS, Westman J. The blood-spinal cord and brain barriers in health and disease. San Diego: Academic Press; 2004. p. 1\u2013617. (Release date: Nov. 9, 2003)"},{"key":"3_CR83","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-0-387-30375-8_17","volume-title":"Handbook of neurochemistry and molecular neurobiology: brain and spinal cord trauma","author":"HS Sharma","year":"2009","unstructured":"Sharma HS. Blood\u2013central nervous system barriers: the gateway to neurodegeneration, neuroprotection and Neuroregeneration. In: Lajtha A, Banik N, Ray SK, editors. Handbook of neurochemistry and molecular neurobiology: brain and spinal cord trauma. Berlin, Heidelberg, New York: Springer Verlag; 2009. p. 363\u2013457."},{"key":"3_CR84","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-012639011-7\/50019-X","volume-title":"The blood-spinal cord and brain barriers in health and disease","author":"HS Sharma","year":"2004","unstructured":"Sharma HS. Blood-brain and spinal cord barriers in stress. In: Sharma HS, Westman J, editors. The blood-spinal cord and brain barriers in health and disease. San Diego: Elsevier Academic Press; 2004. p. 231\u201398."},{"key":"3_CR85","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-012639011-7\/50018-8","volume-title":"The blood-spinal cord and brain barriers in health and disease","author":"HS Sharma","year":"2004","unstructured":"Sharma HS, Alm P. Role of nitric oxide on the blood-brain and the spinal cord barriers. In: Sharma HS, Westman J, editors. The blood-spinal cord and brain barriers in health and disease. San Diego: Elsevier Academic Press; 2004. p. 191\u2013230."},{"key":"3_CR86","doi-asserted-by":"publisher","first-page":"5005136","DOI":"10.1155\/2021\/5005136","volume":"2021","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Song Y, Chen H, Li Q, Gao Y, Lu G, Luo C. Ferroptosis mediated by lipid reactive oxygen species: a possible causal link of neuroinflammation to neurological disorders. Oxidative Med Cell Longev. 2021;2021:5005136. https:\/\/doi.org\/10.1155\/2021\/5005136. eCollection 2021","journal-title":"Oxidative Med Cell Longev"},{"issue":"11","key":"3_CR87","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, Cost\u0103chescu B, Grumezescu AM, Teleanu RI. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci. 2022;23(11):5938. https:\/\/doi.org\/10.3390\/ijms23115938.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3_CR88","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/antiox11010170","volume":"11","author":"S Takahashi","year":"2022","unstructured":"Takahashi S, Mashima K. Neuroprotection and disease modification by astrocytes and microglia in Parkinson disease. Antioxidants (Basel). 2022;11(1):170. https:\/\/doi.org\/10.3390\/antiox11010170.","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"3_CR89","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","volume":"39","author":"E \u00c7\u0131nar","year":"2022","unstructured":"\u00c7\u0131nar E, Tel BC, \u015eahin G. Neuroinflammation in Parkinson\u2019s disease and its treatment opportunities. Balkan Med J. 2022;39(5):318\u201333. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2022.2022-7-100. Epub 2022 Aug 29","journal-title":"Balkan Med J"},{"key":"3_CR90","doi-asserted-by":"publisher","unstructured":"Zucca FA, Capucciati A, Bellei C, Sarna M, Sarna T, Monzani E, Casella L, Zecca L. Neuromelanins in brain aging and Parkinson\u2019s disease: synthesis, structure, neuroinflammatory, and neurodegenerative role. IUBMB Life. 2022; https:\/\/doi.org\/10.1002\/iub.2654. Online ahead of print","DOI":"10.1002\/iub.2654"},{"key":"3_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120220","volume":"436","author":"H Golan","year":"2022","unstructured":"Golan H, Volkov O, Shalom E. Nuclear imaging in Parkinson\u2019s disease: the past, the present, and the future. J Neurol Sci. 2022;436:120220. https:\/\/doi.org\/10.1016\/j.jns.2022.120220. Epub 2022 Mar 9","journal-title":"J Neurol Sci"},{"issue":"6","key":"3_CR92","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","volume":"39","author":"S Prange","year":"2022","unstructured":"Prange S, Klinger H, Laurencin C, Danaila T, Thobois S. Depression in patients with Parkinson\u2019s disease: current understanding of its neurobiology and implications for treatment. Drugs Aging. 2022;39(6):417\u201339. https:\/\/doi.org\/10.1007\/s40266-022-00942-1. Epub 2022 Jun 16","journal-title":"Drugs Aging"},{"issue":"2","key":"3_CR93","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00441-014-1866-0","volume":"357","author":"T Cal\u00ec","year":"2014","unstructured":"Cal\u00ec T, Ottolini D, Brini M. Calcium signaling in Parkinson\u2019s disease. Cell Tissue Res. 2014;357(2):439\u201354. https:\/\/doi.org\/10.1007\/s00441-014-1866-0. Epub 2014 May 1","journal-title":"Cell Tissue Res"},{"issue":"5","key":"3_CR94","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tins.2009.01.006","volume":"32","author":"CS Chan","year":"2009","unstructured":"Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson\u2019s disease. Trends Neurosci. 2009;32(5):249\u201356. https:\/\/doi.org\/10.1016\/j.tins.2009.01.006. Epub 2009 Mar 21","journal-title":"Trends Neurosci"},{"issue":"10","key":"3_CR95","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1474-4422(07)70246-6","volume":"6","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ. Calcium, ageing, and neuronal vulnerability in Parkinson\u2019s disease. Lancet Neurol. 2007;6(10):933\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(07)70246-6.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3_CR96","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1124\/mol.63.4.784","volume":"63","author":"GA de Erausquin","year":"2003","unstructured":"de Erausquin GA, Hyrc K, Dorsey DA, Mamah D, Dokucu M, Masc\u00f3 DH, Walton T, Dikranian K, Soriano M, Garc\u00eda Verdugo JM, Goldberg MP, Dugan LL. Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons. Mol Pharmacol. 2003;63(4):784\u201390. https:\/\/doi.org\/10.1124\/mol.63.4.784.","journal-title":"Mol Pharmacol"},{"issue":"7","key":"3_CR97","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/cells10071737","volume":"10","author":"JT Varughese","year":"2021","unstructured":"Varughese JT, Buchanan SK, Pitt AS. The role of voltage-dependent anion channel in mitochondrial dysfunction and human disease. Cell. 2021;10(7):1737. https:\/\/doi.org\/10.3390\/cells10071737.","journal-title":"Cell"},{"issue":"6","key":"3_CR98","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.24396","volume":"77","author":"RC Gardner","year":"2015","unstructured":"Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015;77(6):987\u201395. https:\/\/doi.org\/10.1002\/ana.24396. Epub 2015 Mar 28","journal-title":"Ann Neurol"},{"issue":"3","key":"3_CR99","doi-asserted-by":"publisher","DOI":"10.1136\/fmch-2020-000390","volume":"8","author":"MP Morissette","year":"2020","unstructured":"Morissette MP, Prior HJ, Tate RB, Wade J, Leiter JRS. Associations between concussion and risk of diagnosis of psychological and neurological disorders: a retrospective population-based cohort study. Fam Med Community Health. 2020;8(3):e000390. https:\/\/doi.org\/10.1136\/fmch-2020-000390.","journal-title":"Fam Med Community Health"},{"issue":"4","key":"3_CR100","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8775","volume":"5","author":"A Phelps","year":"2022","unstructured":"Phelps A, Alosco ML, Baucom Z, Hartlage K, Palmisano JN, Weuve J, Mez J, Tripodis Y, Stern RA. Association of Playing College American Football With Long-term Health Outcomes and Mortality. JAMA Netw Open. 2022;5(4):e228775. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.8775.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3_CR101","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/neu.2018.6196","volume":"38","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang M, Sun C, Wang S, Cao J, Wang KKW, Gan S, Huang W, Niu X, Zhu Y, Sun Y, Bai L. Single mild traumatic brain injury deteriorates progressive interhemispheric functional and structural connectivity. J Neurotrauma. 2021;38(4):464\u201373. https:\/\/doi.org\/10.1089\/neu.2018.6196. Epub 2020 Nov 4","journal-title":"J Neurotrauma"},{"issue":"3","key":"3_CR102","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s11102-019-00957-9","volume":"22","author":"D Pavlovic","year":"2019","unstructured":"Pavlovic D, Pekic S, Stojanovic M, Popovic V. Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae. Pituitary. 2019;22(3):270\u201382. https:\/\/doi.org\/10.1007\/s11102-019-00957-9.","journal-title":"Pituitary"},{"issue":"4","key":"3_CR103","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneurol.2010.18","volume":"6","author":"AS Chen-Plotkin","year":"2010","unstructured":"Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):211\u201320. https:\/\/doi.org\/10.1038\/nrneurol.2010.18. Epub 2010 Mar 16","journal-title":"Nat Rev Neurol"},{"issue":"21","key":"3_CR104","doi-asserted-by":"publisher","first-page":"22313","DOI":"10.18632\/aging.103675","volume":"12","author":"H Zeng","year":"2020","unstructured":"Zeng H, Liu N, Liu XX, Yang YY, Zhou MW. \u03b1-Synuclein in traumatic and vascular diseases of the central nervous system. Aging (Albany NY). 2020;12(21):22313\u201334. https:\/\/doi.org\/10.18632\/aging.103675. Epub 2020 Nov 7","journal-title":"Aging (Albany NY)"},{"key":"3_CR105","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-981-13-3681-2_4","volume":"91","author":"L Walker","year":"2019","unstructured":"Walker L, McAleese KE, Erskine D, Attems J. Neurodegenerative diseases and ageing. Subcell Biochem. 2019;91:75\u2013106. https:\/\/doi.org\/10.1007\/978-981-13-3681-2_4.","journal-title":"Subcell Biochem"},{"key":"3_CR106","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fneur.2013.00079","volume":"4","author":"PP Tsitsopoulos","year":"2013","unstructured":"Tsitsopoulos PP, Marklund N. Amyloid-\u03b2 peptides and tau protein as biomarkers in cerebrospinal and interstitial fluid following traumatic brain injury: a review of experimental and clinical studies. Front Neurol. 2013;4:79. https:\/\/doi.org\/10.3389\/fneur.2013.00079. eCollection 2013","journal-title":"Front Neurol"},{"issue":"8","key":"3_CR107","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA, Stark KL, Foreman O, Carano RAD, Friedman BA, Sheng M, Easton A, Bohlen CJ, Hansen DV. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109(8):1283\u20131301.e6. https:\/\/doi.org\/10.1016\/j.neuron.2021.02.010. Epub 2021 Mar 5","journal-title":"Neuron"},{"issue":"10","key":"3_CR108","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/alz.12131","volume":"16","author":"M Mil\u00e0-Alom\u00e0","year":"2020","unstructured":"Mil\u00e0-Alom\u00e0 M, Salvad\u00f3 G, Gispert JD, Vilor-Tejedor N, Grau-Rivera O, Sala-Vila A, S\u00e1nchez-Benavides G, Arenaza-Urquijo EM, Crous-Bou M, Gonz\u00e1lez-de-Ech\u00e1varri JM, Minguillon C, Fauria K, Simon M, Kollmorgen G, Zetterberg H, Blennow K, Su\u00e1rez-Calvet M, Molinuevo JL, ALFA study. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum. Alzheimers Dement. 2020;16(10):1358\u201371. https:\/\/doi.org\/10.1002\/alz.12131. Epub 2020 Jun 23","journal-title":"Alzheimers Dement"},{"issue":"15","key":"3_CR109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY, Poggiolini I, Santos P, Dorn A, Carloni P, Vekrellis K, Attems J, McKeith I, Outeiro TF, Jensen PH, El-Agnaf OMA. \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci U S A. 2022;119(15):e2109617119. https:\/\/doi.org\/10.1073\/pnas.2109617119. Epub","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3_CR110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-021-00509-5","volume":"17","author":"E Xu","year":"2022","unstructured":"Xu E, Boddu R, Abdelmotilib HA, Sokratian A, Kelly K, Liu Z, Bryant N, Chandra S, Carlisle SM, Lefkowitz EJ, Harms AS, Benveniste EN, Yacoubian TA, Volpicelli-Daley LA, Standaert DG, West AB. Pathological \u03b1-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain. Mol Neurodegener. 2022;17(1):7. https:\/\/doi.org\/10.1186\/s13024-021-00509-5.","journal-title":"Mol Neurodegener"},{"key":"3_CR111","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/B978-0-12-819410-2.00023-0","volume":"184","author":"F Garretti","year":"2022","unstructured":"Garretti F, Monahan C, Sette A, Agalliu D, Sulzer D. T cells, \u03b1-synuclein and Parkinson disease. Handb Clin Neurol. 2022;184:439\u201355. https:\/\/doi.org\/10.1016\/B978-0-12-819410-2.00023-0.","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"3_CR112","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell. 2019;18(6):e13031. https:\/\/doi.org\/10.1111\/acel.13031. Epub 2019 Aug 20","journal-title":"Aging Cell"},{"key":"3_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"L Mahoney-S\u00e1nchez","year":"2021","unstructured":"Mahoney-S\u00e1nchez L, Bouchaoui H, Ayton S, Devos D, Duce JA, Devedjian JC. Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease. Prog Neurobiol. 2021;196:101890. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101890. Epub 2020 Jul 26","journal-title":"Prog Neurobiol"},{"key":"3_CR114","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.toxrep.2021.03.009","volume":"8","author":"I Ullah","year":"2021","unstructured":"Ullah I, Zhao L, Hai Y, Fahim M, Alwayli D, Wang X, Li H. Metal elements and pesticides as risk factors for Parkinson\u2019s disease \u2013 a review. Toxicol Rep. 2021;8:607\u201316. https:\/\/doi.org\/10.1016\/j.toxrep.2021.03.009. eCollection 2021","journal-title":"Toxicol Rep"},{"issue":"6","key":"3_CR115","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1212\/wnl.48.6.1583","volume":"48","author":"HH Liou","year":"1997","unstructured":"Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC. Environmental risk factors and Parkinson\u2019s disease: a case-control study in Taiwan. Neurology. 1997;48(6):1583\u20138. https:\/\/doi.org\/10.1212\/wnl.48.6.1583.","journal-title":"Neurology"},{"issue":"6","key":"3_CR116","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1471-4159.2010.07036.x","volume":"115","author":"J Peng","year":"2010","unstructured":"Peng J, Oo ML, Andersen JK. Synergistic effects of environmental risk factors and gene mutations in Parkinson\u2019s disease accelerate age-related neurodegeneration. J Neurochem. 2010;115(6):1363\u201373. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07036.x. Epub 2010 Nov 4","journal-title":"J Neurochem"},{"issue":"5\u20136","key":"3_CR117","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000321342","volume":"32","author":"E Su","year":"2010","unstructured":"Su E, Bell MJ, Wisniewski SR, Adelson PD, Janesko-Feldman KL, Salonia R, Clark RS, Kochanek PM, Kagan VE, Bay\u0131r H. \u03b1-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev Neurosci. 2010;32(5\u20136):385\u201395. https:\/\/doi.org\/10.1159\/000321342. Epub 2010 Dec 2","journal-title":"Dev Neurosci"},{"issue":"18","key":"3_CR118","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3182904d43","volume":"80","author":"S Mondello","year":"2013","unstructured":"Mondello S, Buki A, Italiano D, Jeromin A. \u03b1-Synuclein in CSF of patients with severe traumatic brain injury. Neurology. 2013;80(18):1662\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e3182904d43. Epub 2013 Apr 3","journal-title":"Neurology"},{"issue":"2","key":"3_CR119","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(21)00375-6","volume":"21","author":"JP Chhatwal","year":"2022","unstructured":"Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, Sung YJ, Lee JH, Klunk WE, Hofmann A, Noble JM, Graff-Radford N, Mori H, Salloway SM, Masters CL, Martins R, Karch CM, Xiong C, Cruchaga C, Perrin RJ, Gordon BA, Benzinger TLS, Fox NC, Schofield PR, Fagan AM, Goate AM, Morris JC, Bateman RJ, Johnson KA, Sperling RA, Dominantly Inherited Alzheimer\u2019s Network Investigators. Variant-dependent heterogeneity in amyloid \u03b2 burden in autosomal dominant Alzheimer\u2019s disease: cross-sectional and longitudinal analyses of an observational study. Lancet Neurol. 2022;21(2):140\u201352. https:\/\/doi.org\/10.1016\/S1474-4422(21)00375-6.","journal-title":"Lancet Neurol"},{"issue":"6577","key":"3_CR120","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang Y, Arseni D, Zhang W, Huang M, L\u00f6vestam S, Schweighauser M, Kotecha A, Murzin AG, Peak-Chew SY, Macdonald J, Lavenir I, Garringer HJ, Gelpi E, Newell KL, Kovacs GG, Vidal R, Ghetti B, Ryskeldi-Falcon B, Scheres SHW, Goedert M. Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains. Science. 2022;375(6577):167\u201372. https:\/\/doi.org\/10.1126\/science.abm7285. Epub 2022 Jan 13","journal-title":"Science"},{"issue":"4","key":"3_CR121","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jnc.15538","volume":"160","author":"MM Matuszyk","year":"2022","unstructured":"Matuszyk MM, Garwood CJ, Ferraiuolo L, Simpson JE, Staniforth RA, Wharton SB. Biological and methodological complexities of beta-amyloid peptide: implications for Alzheimer\u2019s disease research. J Neurochem. 2022;160(4):434\u201353. https:\/\/doi.org\/10.1111\/jnc.15538. Epub 2021 Nov 24","journal-title":"J Neurochem"},{"issue":"7","key":"3_CR122","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1212\/WNL.0000000000013211","volume":"98","author":"Y Li","year":"2022","unstructured":"Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Shaw LM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ. Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer disease amyloid plaques. Neurology. 2022;98(7):e688\u201399. https:\/\/doi.org\/10.1212\/WNL.0000000000013211. Epub 2021 Dec 14","journal-title":"Neurology"},{"issue":"1","key":"3_CR123","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"JA Trejo-Lopez","year":"2022","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S. Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics. 2022;19(1):173\u201385. https:\/\/doi.org\/10.1007\/s13311-021-01146-y. Epub 2021 Nov 2","journal-title":"Neurotherapeutics"},{"issue":"48","key":"3_CR124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112783118","volume":"118","author":"V Lattanzi","year":"2021","unstructured":"Lattanzi V, Andr\u00e9 I, Gasser U, Dubackic M, Olsson U, Linse S. Amyloid \u03b2 42 fibril structure based on small-angle scattering. Proc Natl Acad Sci U S A. 2021;118(48):e2112783118. https:\/\/doi.org\/10.1073\/pnas.2112783118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR125","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnmol.2019.00054","volume":"12","author":"J Lu","year":"2019","unstructured":"Lu J, Cao Q, Wang C, Zheng J, Luo F, Xie J, Li Y, Ma X, He L, Eisenberg D, Nowick J, Jiang L, Li D. Structure-based peptide inhibitor design of amyloid-\u03b2 aggregation. Front Mol Neurosci. 2019;12:54. https:\/\/doi.org\/10.3389\/fnmol.2019.00054. eCollection 2019","journal-title":"Front Mol Neurosci"},{"key":"3_CR126","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neures.2022.03.001","volume":"180","author":"K Taniguchi","year":"2022","unstructured":"Taniguchi K, Yamamoto F, Amano A, Tamaoka A, Sanjo N, Yokota T, Kametani F, Araki W. Amyloid-\u03b2 oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: relevance to the synapse pathology of Alzheimer\u2019s disease. Neurosci Res. 2022;180:90\u20138. https:\/\/doi.org\/10.1016\/j.neures.2022.03.001. Epub 2022 Mar 5","journal-title":"Neurosci Res"},{"issue":"7","key":"3_CR127","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ajpath.2014.03.014","volume":"184","author":"E Barbero-Camps","year":"2014","unstructured":"Barbero-Camps E, Fern\u00e1ndez A, Baulies A, Martinez L, Fern\u00e1ndez-Checa JC, Colell A. Endoplasmic reticulum stress mediates amyloid \u03b2 neurotoxicity via mitochondrial cholesterol trafficking. Am J Pathol. 2014;184(7):2066\u201381. https:\/\/doi.org\/10.1016\/j.ajpath.2014.03.014. Epub 2014 May 9","journal-title":"Am J Pathol"},{"issue":"12","key":"3_CR128","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.bbadis.2013.08.007","volume":"1832","author":"AC Fonseca","year":"2013","unstructured":"Fonseca AC, Ferreiro E, Oliveira CR, Cardoso SM, Pereira CF. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1\u201340 peptide in brain endothelial cells. Biochim Biophys Acta. 2013;1832(12):2191\u2013203. https:\/\/doi.org\/10.1016\/j.bbadis.2013.08.007. Epub 2013","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3_CR129","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","volume":"22","author":"VE Johnson","year":"2012","unstructured":"Johnson VE, Stewart W, Smith DH. Widespread \u03c4 and amyloid-\u03b2 pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012;22(2):142\u20139. https:\/\/doi.org\/10.1111\/j.1750-3639.2011.00513.x. Epub 2011 Sep 12","journal-title":"Brain Pathol"},{"key":"3_CR130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","volume":"28","author":"J Ramos-Cejudo","year":"2018","unstructured":"Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, Fossati S. Traumatic brain injury and Alzheimer\u2019s disease: the cerebrovascular link. EBioMedicine. 2018;28:21\u201330. https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.021. Epub 2018 Jan 31","journal-title":"EBioMedicine"},{"issue":"1","key":"3_CR131","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-020-00924-7","volume":"8","author":"V Delic","year":"2020","unstructured":"Delic V, Beck KD, Pang KCH, Citron BA. Biological links between traumatic brain injury and Parkinson\u2019s disease. Acta Neuropathol Commun. 2020;8(1):45. https:\/\/doi.org\/10.1186\/s40478-020-00924-7.","journal-title":"Acta Neuropathol Commun"},{"issue":"21","key":"3_CR132","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2001;98(21):12245\u201350. https:\/\/doi.org\/10.1073\/pnas.211412398. Epub 2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3_CR133","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000430952","volume":"15","author":"S Krassnig","year":"2015","unstructured":"Krassnig S, Schweinzer C, Taub N, Havas D, Auer E, Flunkert S, Schreibmayer W, Hutter-Paier B, Windisch M. Influence of lentiviral \u03b2-synuclein overexpression in the hippocampus of a transgenic mouse model of Alzheimer\u2019s disease on amyloid precursor protein metabolism and pathology. Neurodegener Dis. 2015;15(4):243\u201357. https:\/\/doi.org\/10.1159\/000430952. Epub 2015 Jun 25","journal-title":"Neurodegener Dis"},{"issue":"21","key":"3_CR134","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci. 2010;30(21):7281\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.0490-10.2010.","journal-title":"J Neurosci"},{"issue":"10","key":"3_CR135","doi-asserted-by":"publisher","first-page":"166203","DOI":"10.1016\/j.bbadis.2021.166203","volume":"1867","author":"X Huang","year":"2021","unstructured":"Huang X, Wang C, Chen L, Zhang T, Leung KL, Wong G. Human amyloid beta and \u03b1-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans. Biochim Biophys Acta Mol basis Dis. 2021;1867(10):166203.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"2","key":"3_CR136","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1152\/physrev.00024.2003","volume":"84","author":"J Avila","year":"2004","unstructured":"Avila J, Lucas JJ, Perez M, Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev. 2004;84(2):361\u201384. https:\/\/doi.org\/10.1152\/physrev.00024.2003.","journal-title":"Physiol Rev"},{"issue":"4","key":"3_CR137","first-page":"1141","volume":"58","author":"DFV P\u00eer\u015fcoveanu","year":"2017","unstructured":"P\u00eer\u015fcoveanu DFV, Pirici I, Tudoric\u0103 V, B\u0103l\u015feanu TA, Albu VC, Bondari S, Bumbea AM, P\u00eer\u015fcoveanu M. Tau protein in neurodegenerative diseases \u2013 a review. Romanian J Morphol Embryol. 2017;58(4):1141\u201350.","journal-title":"Romanian J Morphol Embryol"},{"issue":"1","key":"3_CR138","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5\u201321. https:\/\/doi.org\/10.1038\/nrn.2015.1. Epub 2015 Dec 3","journal-title":"Nat Rev Neurosci"},{"key":"3_CR139","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.forsciint.2019.05.010","volume":"301","author":"M Olczak","year":"2019","unstructured":"Olczak M, Poniatowski \u0141A, Niderla-Bieli\u0144ska J, Kwiatkowska M, Chutora\u0144ski D, Tarka S, Wierzba-Bobrowicz T. Concentration of microtubule associated protein tau (MAPT) in urine and saliva as a potential biomarker of traumatic brain injury in relationship with blood-brain barrier disruption in postmortem examination. Forensic Sci Int. 2019;301:28\u201336. https:\/\/doi.org\/10.1016\/j.forsciint.2019.05.010. Epub 2019 May 13","journal-title":"Forensic Sci Int"},{"issue":"1","key":"3_CR140","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12987-021-00283-y","volume":"18","author":"M Eisenbaum","year":"2021","unstructured":"Eisenbaum M, Pearson A, Gratkowski A, Mouzon B, Mullan M, Crawford F, Ojo J, Bachmeier C. Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier. Fluids Barriers CNS. 2021;18(1):48. https:\/\/doi.org\/10.1186\/s12987-021-00283-y.","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"3_CR141","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neurobiolaging.2004.09.019","volume":"26","author":"AL Guillozet-Bongaarts","year":"2005","unstructured":"Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI. Tau truncation during neurofibrillary tangle evolution in Alzheimer\u2019s disease. Neurobiol Aging. 2005;26(7):1015\u201322. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.09.019. Epub 2004 Dec 16","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3_CR142","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/jad-2003-5201","volume":"5","author":"F Garc\u00eda-Sierra","year":"2003","unstructured":"Garc\u00eda-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer\u2019s disease. J Alzheimers Dis. 2003;5(2):65\u201377. https:\/\/doi.org\/10.3233\/jad-2003-5201.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3_CR143","first-page":"123","volume":"60","author":"SC Papasozomenos","year":"1989","unstructured":"Papasozomenos SC. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. Lab Investig. 1989;60(1):123\u201337.","journal-title":"Lab Investig"},{"issue":"9","key":"3_CR144","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","volume":"33","author":"T Haggerty","year":"2011","unstructured":"Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A. Hyperphosphorylated tau in an \u03b1-synuclein-overexpressing transgenic model of Parkinson\u2019s disease. Eur J Neurosci. 2011;33(9):1598\u2013610. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07660.x. Epub 2011 Apr 1","journal-title":"Eur J Neurosci"},{"issue":"13","key":"3_CR145","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.3390\/ijerph18136689","volume":"18","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2021","unstructured":"Calder\u00f3n-Garcidue\u00f1as L, Rajkumar RP, Stommel EW, Kulesza R, Mansour Y, Rico-Villanueva A, Flores-V\u00e1zquez JO, Brito-Aguilar R, Ram\u00edrez-S\u00e1nchez S, Garc\u00eda-Alonso G, Ch\u00e1vez-Franco DA, Lu\u00e9vano-Castro SC, Garc\u00eda-Rojas E, Revueltas-Ficachi P, Villarreal-R\u00edos R, Mukherjee PS. Brainstem quadruple aberrant hyperphosphorylated tau, beta-amyloid, alpha-synuclein and TDP-43 pathology, stress and sleep behavior disorders. Int J Environ Res Public Health. 2021;18(13):6689. https:\/\/doi.org\/10.3390\/ijerph18136689.","journal-title":"Int J Environ Res Public Health"},{"key":"3_CR146","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/NDT.S90735","volume":"12","author":"Y Guo","year":"2016","unstructured":"Guo Y, Wang L, Zhu M, Zhang H, Hu Y, Han Z, Liu J, Zhao W, Wang D. Detection of hyperphosphorylated tau protein and \u03b1-synuclein in spinal cord of patients with Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2016;12:445\u201352. https:\/\/doi.org\/10.2147\/NDT.S90735. eCollection 2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"3_CR147","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/neu.2018.6348","volume":"37","author":"G Edwards 3rd","year":"2020","unstructured":"Edwards G 3rd, Zhao J, Dash PK, Soto C, Moreno-Gonzalez I. Traumatic brain injury induces tau aggregation and spreading. J Neurotrauma. 2020;37(1):80\u201392. https:\/\/doi.org\/10.1089\/neu.2018.6348. Epub 2019 Aug 28","journal-title":"J Neurotrauma"},{"issue":"1","key":"3_CR148","doi-asserted-by":"publisher","first-page":"fcz004","DOI":"10.1093\/braincomms\/fcz004","volume":"1","author":"A Bittar","year":"2019","unstructured":"Bittar A, Bhatt N, Hasan TF, Montalbano M, Puangmalai N, McAllen S, Ellsworth A, Carretero Murillo M, Taglialatela G, Lucke-Wold B, Logsdon A, Rosen C, Turner RC, Kayed R. Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury. Brain Commun. 2019;1(1):fcz004. https:\/\/doi.org\/10.1093\/braincomms\/fcz004. Epub 2019 Jun 28","journal-title":"Brain Commun"},{"issue":"1","key":"3_CR149","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/alzrt234","volume":"6","author":"TD Stein","year":"2014","unstructured":"Stein TD, Alvarez VE, McKee AC. Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimers Res Ther. 2014;6(1):4. https:\/\/doi.org\/10.1186\/alzrt234. eCollection 2014","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"3_CR150","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11916-015-0522-z","volume":"19","author":"TD Stein","year":"2015","unstructured":"Stein TD, Alvarez VE, McKee AC. Concussion in chronic traumatic encephalopathy. Curr Pain Headache Rep. 2015;19(10):47. https:\/\/doi.org\/10.1007\/s11916-015-0522-z.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"3_CR151","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024059","volume":"8","author":"J Kriegel","year":"2018","unstructured":"Kriegel J, Papadopoulos Z, McKee AC. Chronic traumatic encephalopathy: is latency in symptom onset explained by tau propagation? Cold Spring Harb Perspect Med. 2018;8(2):a024059. https:\/\/doi.org\/10.1101\/cshperspect.a024059.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"3_CR152","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1093\/brain\/awz238","volume":"142","author":"K Takahata","year":"2019","unstructured":"Takahata K, Kimura Y, Sahara N, Koga S, Shimada H, Ichise M, Saito F, Moriguchi S, Kitamura S, Kubota M, Umeda S, Niwa F, Mizushima J, Morimoto Y, Funayama M, Tabuchi H, Bieniek KF, Kawamura K, Zhang MR, Dickson DW, Mimura M, Kato M, Suhara T, Higuchi M. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. Brain. 2019;142(10):3265\u201379. https:\/\/doi.org\/10.1093\/brain\/awz238.","journal-title":"Brain"},{"issue":"1","key":"3_CR153","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JAD-200526","volume":"78","author":"RQ Zhang","year":"2020","unstructured":"Zhang RQ, Chen SD, Shen XN, Yang YX, Lu JY, Cui M, Zuo CT, Dong Q, Tan L, Yu JT, Alzheimer\u2019s Disease Neuroimaging Initiative. Elevated tau PET signal depends on abnormal amyloid levels and correlates with cognitive impairment in elderly persons without dementia. J Alzheimers Dis. 2020;78(1):395\u2013404. https:\/\/doi.org\/10.3233\/JAD-200526.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3_CR154","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15(1):45. https:\/\/doi.org\/10.1186\/s13024-020-00397-1.","journal-title":"Mol Neurodegener"},{"key":"3_CR155","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25. https:\/\/doi.org\/10.3389\/fnmol.2019.00025. eCollection 2019","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"3_CR156","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1074\/jbc.M109.061846","volume":"285","author":"CF Sephton","year":"2010","unstructured":"Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P 3rd, Herz J, Yu G. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem. 2010;285(9):6826\u201334. https:\/\/doi.org\/10.1074\/jbc.M109.061846. Epub 2009 Dec 29","journal-title":"J Biol Chem"},{"issue":"7832","key":"3_CR157","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41586-020-2703-0","volume":"587","author":"A Pandya-Jones","year":"2020","unstructured":"Pandya-Jones A, Markaki Y, Serizay J, Chitiashvili T, Mancia Leon WR, Damianov A, Chronis C, Papp B, Chen CK, McKee R, Wang XJ, Chau A, Sabri S, Leonhardt H, Zheng S, Guttman M, Black DL, Plath K. A protein assembly mediates Xist localization and gene silencing. Nature. 2020;587(7832):145\u201351. https:\/\/doi.org\/10.1038\/s41586-020-2703-0. Epub 2020 Sep 9","journal-title":"Nature"},{"key":"3_CR158","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fneur.2019.00680","volume":"10","author":"L Heyburn","year":"2019","unstructured":"Heyburn L, Sajja VSSS, Long JB. The role of TDP-43 in military-relevant TBI and chronic neurodegeneration. Front Neurol. 2019;10:680. https:\/\/doi.org\/10.3389\/fneur.2019.00680. eCollection 2019","journal-title":"Front Neurol"},{"issue":"313","key":"3_CR159","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2017.10.011","volume":"15","author":"CY Huang","year":"2017","unstructured":"Huang CY, Lee YC, Li PC, Liliang PC, Lu K, Wang KW, Chang LC, Shiu LY, Chen MF, Sun YT, Wang HK. TDP-43 proteolysis is associated with astrocyte reactivity after traumatic brain injury in rodents. J Neuroimmunol. 2017;15(313):61\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.10.011. Epub 2017 Oct 20","journal-title":"J Neuroimmunol"},{"issue":"2","key":"3_CR160","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-022-02449-w","volume":"144","author":"F Gao","year":"2022","unstructured":"Gao F, Hu M, Zhang J, Hashem J, Chen C. TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury. Acta Neuropathol. 2022;144(2):187\u2013210. https:\/\/doi.org\/10.1007\/s00401-022-02449-w. Epub 2022 Jun 17","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3_CR161","doi-asserted-by":"publisher","first-page":"166953","DOI":"10.1016\/j.jmb.2021.166953","volume":"433","author":"S Dhakal","year":"2021","unstructured":"Dhakal S, Wyant CE, George HE, Morgan SE, Rangachari V. J prion-like C-terminal domain of TDP-43 and \u03b1-synuclein interact synergistically to generate neurotoxic hybrid fibrils. Mol Biol. 2021;433(10):166953. https:\/\/doi.org\/10.1016\/j.jmb.2021.166953. Epub 2021 Mar 24","journal-title":"Mol Biol"},{"issue":"6","key":"3_CR162","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/acs.biochem.6b01088","volume":"56","author":"Y Sun","year":"2017","unstructured":"Sun Y, Chakrabartty A. Phase to phase with TDP-43. Biochemistry. 2017;56(6):809\u201323. https:\/\/doi.org\/10.1021\/acs.biochem.6b01088. Epub 2017 Jan 30","journal-title":"Biochemistry"},{"issue":"7","key":"3_CR163","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mds.29048","volume":"37","author":"R Yamashita","year":"2022","unstructured":"Yamashita R, Beck G, Yonenobu Y, Inoue K, Mitsutake A, Ishiura H, Hasegawa M, Murayama S, Mochizuki H. TDP-43 Proteinopathy presenting with typical symptoms of Parkinson\u2019s disease. Mov Disord. 2022;37(7):1561\u20133. https:\/\/doi.org\/10.1002\/mds.29048. Epub 2022 May 9","journal-title":"Mov Disord"},{"issue":"1","key":"3_CR164","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00401-013-1110-0","volume":"126","author":"SJ Arnold","year":"2013","unstructured":"Arnold SJ, Dugger BN, Beach TG. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol. 2013;126(1):51\u20137. https:\/\/doi.org\/10.1007\/s00401-013-1110-0. Epub 2013 Apr 20","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3_CR165","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2174\/1567205017666201130094259","volume":"17","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Lee JH, Cheong EN, Chung SE, Jo S, Shim WH, Hong YJ. Elucidating the risk factors for progression from amyloid-negative amnestic mild cognitive impairment to dementia. Curr Alzheimer Res. 2020;17(10):893\u2013903. https:\/\/doi.org\/10.2174\/1567205017666201130094259.","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"3_CR166","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.neurobiolaging.2011.03.007","volume":"33","author":"N Xiong","year":"2012","unstructured":"Xiong N, Huang J, Chen C, Zhao Y, Zhang Z, Jia M, Zhang Z, Hou L, Yang H, Cao X, Liang Z, Zhang Y, Sun S, Lin Z, Wang T. Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson\u2019s disease. Neurobiol Aging. 2012;33(8):1777\u201391. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.007. Epub 2011 Apr 23","journal-title":"Neurobiol Aging"},{"key":"3_CR167","doi-asserted-by":"publisher","first-page":"8868941","DOI":"10.1155\/2021\/8868941","volume":"2021","author":"T Zhu","year":"2021","unstructured":"Zhu T, Wang L, Feng Y, Sun G, Sun X. Classical active ingredients and extracts of Chinese herbal medicines: pharmacokinetics, pharmacodynamics, and molecular mechanisms for ischemic stroke. Oxidative Med Cell Longev. 2021;2021:8868941. https:\/\/doi.org\/10.1155\/2021\/8868941. eCollection 2021","journal-title":"Oxidative Med Cell Longev"},{"key":"3_CR168","doi-asserted-by":"publisher","first-page":"632374","DOI":"10.3389\/fnagi.2021.632374","volume":"13","author":"Y Feng","year":"2021","unstructured":"Feng Y, Guo M, Zhao H, Han S, Hao Y, Yuan Y, Shen W, Sun J, Dong Q, Cui M. Dl-3-n-butylphthalide alleviates demyelination and improves cognitive function by promoting mitochondrial dynamics in white matter lesions. Front Aging Neurosci. 2021;13:632374. https:\/\/doi.org\/10.3389\/fnagi.2021.632374. eCollection 2021","journal-title":"Front Aging Neurosci"},{"key":"3_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.794770","volume":"12","author":"R Que","year":"2021","unstructured":"Que R, Zheng J, Chang Z, Zhang W, Li H, Xie Z, Huang Z, Wang HT, Xu J, Jin D, Yang W, Tan EK, Wang Q. Dl-3-n-butylphthalide rescues dopaminergic neurons in Parkinson\u2019s disease models by inhibiting the NLRP3 inflammasome and ameliorating mitochondrial impairment. Front Immunol. 2021;12:794770. https:\/\/doi.org\/10.3389\/fimmu.2021.794770. eCollection 2021","journal-title":"Front Immunol"},{"issue":"6","key":"3_CR170","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3892\/br.2019.1246","volume":"11","author":"R Luo","year":"2019","unstructured":"Luo R, Wangqin R, Zhu L, Bi W. Neuroprotective mechanisms of 3-n-butylphthalide in neurodegenerative diseases. Biomed Rep. 2019;11(6):235\u201340. https:\/\/doi.org\/10.3892\/br.2019.1246. Epub 2019 Oct 16","journal-title":"Biomed Rep"},{"issue":"11","key":"3_CR171","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1089\/ars.2017.7440","volume":"30","author":"CY Wang","year":"2019","unstructured":"Wang CY, Xu Y, Wang X, Guo C, Wang T, Wang ZY. Dl-3-n-butylphthalide inhibits NLRP3 Inflammasome and mitigates Alzheimer\u2019s-like pathology via Nrf2-TXNIP-TrX Axis. Antioxid Redox Signal. 2019;30(11):1411\u201331. https:\/\/doi.org\/10.1089\/ars.2017.7440. Epub 2018 Apr 25","journal-title":"Antioxid Redox Signal"},{"key":"3_CR172","doi-asserted-by":"publisher","first-page":"5012341","DOI":"10.1155\/2016\/5012341","volume":"2016","author":"IA Abdoulaye","year":"2016","unstructured":"Abdoulaye IA, Guo YJ. A review of recent advances in neuroprotective potential of 3-N-butylphthalide and its derivatives. Biomed Res Int. 2016;2016:5012341. https:\/\/doi.org\/10.1155\/2016\/5012341. Epub 2016 Dec 8","journal-title":"Biomed Res Int"},{"key":"3_CR173","doi-asserted-by":"publisher","first-page":"647266","DOI":"10.3389\/fnins.2021.647266","volume":"15","author":"H Li","year":"2021","unstructured":"Li H, Wang H, Zhang L, Wang M, Li Y. Dl-3-n-butylphthalide alleviates behavioral and cognitive symptoms via modulating mitochondrial dynamics in the A53T-\u03b1-synuclein mouse model of Parkinson\u2019s disease. Front Neurosci. 2021;15:647266. https:\/\/doi.org\/10.3389\/fnins.2021.647266. eCollection 2021","journal-title":"Front Neurosci"},{"key":"3_CR174","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fnagi.2019.00044","volume":"11","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wu T, Li H, Li X, Li Q, Zhu X, Yu M, Kuo SH, Huang F, Wu YC. Dl-3-n-butylphthalide exerts dopaminergic neuroprotection through inhibition of neuroinflammation. Front Aging Neurosci. 2019;11:44. https:\/\/doi.org\/10.3389\/fnagi.2019.00044. eCollection 2019","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"3_CR175","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.3892\/mmr.2017.8332","volume":"17","author":"Y Chen","year":"2018","unstructured":"Chen Y, Jiang M, Li L, Ye M, Yu M, Zhang L, Ge B, Xu W, Wei D. DL-3-n-butylphthalide reduces microglial activation in lipopolysaccharide-induced Parkinson\u2019s disease model mice. Mol Med Rep. 2018;17(3):3884\u201390. https:\/\/doi.org\/10.3892\/mmr.2017.8332. Epub 2017 Dec 20","journal-title":"Mol Med Rep"},{"issue":"24","key":"3_CR176","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016082","volume":"98","author":"R Zhong","year":"2019","unstructured":"Zhong R, Chen Q, Zhang X, Li M, Lin W. L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019;98(24):e16082. https:\/\/doi.org\/10.1097\/MD.0000000000016082.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"3_CR177","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/cns.13952","volume":"28","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Han C, Xia Y, Wan F, Yin S, Li Y, Kou L, Chi X, Hu J, Sun Y, Wu J, Zou W, Huang J, Wang T. Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: a systematic review and meta-analysis. CNS Neurosci Ther. 2022;28(11):1706\u201317. https:\/\/doi.org\/10.1111\/cns.13952. Epub 2022 Sep 1","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"3_CR178","doi-asserted-by":"publisher","first-page":"e045559","DOI":"10.1136\/bmjopen-2020-045559","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang A, Zhang JY, Jia B, Huo X, Zuo Y, Tian X, Wang Y, Miao Z, BAST study investigators. Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): study protocol for a randomised placebo-controlled trial. BMJ Open. 2021;11(5):e045559. https:\/\/doi.org\/10.1136\/bmjopen-2020-045559.","journal-title":"BMJ Open"},{"key":"3_CR179","doi-asserted-by":"publisher","first-page":"810297","DOI":"10.3389\/fphar.2021.810297","volume":"12","author":"X Fan","year":"2022","unstructured":"Fan X, Shen W, Wang L, Zhang Y. Efficacy and safety of DL-3-n-butylphthalide in the treatment of poststroke cognitive impairment: a systematic review and meta-analysis. Front Pharmacol. 2022;12:810297. https:\/\/doi.org\/10.3389\/fphar.2021.810297. eCollection 2021","journal-title":"Front Pharmacol"},{"issue":"46","key":"3_CR180","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023236","volume":"99","author":"L Zhou","year":"2020","unstructured":"Zhou L, Yang R, Wu F. Efficacy and safety of butylphthalide as adjunctive therapy for vascular dementia: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020;99(46):e23236. https:\/\/doi.org\/10.1097\/MD.0000000000023236.","journal-title":"Medicine (Baltimore)"},{"key":"3_CR181","doi-asserted-by":"publisher","first-page":"720664","DOI":"10.3389\/fneur.2021.720664","volume":"12","author":"Z Tan","year":"2021","unstructured":"Tan Z, Zhao Y, Yang W, He S, Ding Y, Xu A. Efficacy and safety of adherence to dl-3-n-butylphthalide treatment in patients with non-disabling minor stroke and TIA-analysis from a nationwide, multicenter registry. Front Neurol. 2021;12:720664. https:\/\/doi.org\/10.3389\/fneur.2021.720664. eCollection 2021","journal-title":"Front Neurol"},{"key":"3_CR182","doi-asserted-by":"publisher","first-page":"924747","DOI":"10.3389\/fphar.2022.924747","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Cui R, Fan F, Lu Y, Ai Y, Liu H, Liu S, Du Y, Qin Z, Sun W, Yu Q, Liu Q, Cheng Y. The efficacy and safety of ischemic stroke therapies: An umbrella review. Front Pharmacol. 2022;13:924747. https:\/\/doi.org\/10.3389\/fphar.2022.924747. eCollection 2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"3_CR183","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1142\/S0192415X19500265","volume":"47","author":"ZQ Xu","year":"2019","unstructured":"Xu ZQ, Zhou Y, Shao BZ, Zhang JJ, Liu C. A systematic review of neuroprotective efficacy and safety of DL-3-N-butylphthalide in ischemic stroke. Am J Chin Med. 2019;47(3):507\u201325. https:\/\/doi.org\/10.1142\/S0192415X19500265. Epub 2019 Apr 9","journal-title":"Am J Chin Med"},{"issue":"5","key":"3_CR184","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3892\/etm.2019.7397","volume":"17","author":"H Zhou","year":"2019","unstructured":"Zhou H, Ye M, Xu W, Yu M, Liu X, Chen Y. DL-3-n-butylphthalide therapy for Parkinson\u2019s disease: a randomized controlled trial. Exp Ther Med. 2019;17(5):3800\u20136. https:\/\/doi.org\/10.3892\/etm.2019.7397. Epub 2019 Mar 14","journal-title":"Exp Ther Med"},{"key":"3_CR185","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuint.2017.03.017","volume":"111","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Lee JH, Chen D, Gu X, Caslin A, Li J, Yu SP, Wei L. DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice. Neurochem Int. 2017;111:82\u201392. https:\/\/doi.org\/10.1016\/j.neuint.2017.03.017. Epub 2017 Mar 28","journal-title":"Neurochem Int"},{"issue":"5","key":"3_CR186","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s11064-017-2186-z","volume":"42","author":"Z Liu","year":"2017","unstructured":"Liu Z, Wang H, Shi X, Li L, Zhou M, Ding H, Yang Y, Li X, Ding K. DL-3-n-butylphthalide (NBP) provides neuroprotection in the mice models after traumatic brain injury via Nrf2-ARE signaling pathway. Neurochem Res. 2017;42(5):1375\u201386. https:\/\/doi.org\/10.1007\/s11064-017-2186-z. Epub 2017 Feb 18","journal-title":"Neurochem Res"},{"issue":"11","key":"3_CR187","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1111\/jcmm.13212","volume":"21","author":"Z He","year":"2017","unstructured":"He Z, Zhou Y, Lin L, Wang Q, Khor S, Mao Y, Li J, Zhen Z, Chen J, Gao Z, Wu F, Zhang X, Zhang H, Xu HZ, Wang Z, Xiao J. Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4\/NF-\u03baB signalling. J Cell Mol Med. 2017;21(11):3010\u201322. https:\/\/doi.org\/10.1111\/jcmm.13212. Epub 2017 Aug 25","journal-title":"J Cell Mol Med"},{"key":"3_CR188","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/bs.irn.2019.06.009","volume":"146","author":"S Sahib","year":"2019","unstructured":"Sahib S, Niu F, Sharma A, Feng L, Tian ZR, Muresanu DF, Nozari A, Sharma HS. Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation. Int Rev Neurobiol. 2019;146:153\u201388. https:\/\/doi.org\/10.1016\/bs.irn.2019.06.009. Epub 2019 Jul 8","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"3_CR189","first-page":"1075","volume":"9","author":"Z He","year":"2017","unstructured":"He Z, Zhou Y, Huang Y, Wang Q, Zheng B, Zhang H, Li J, Liu Y, Wu F, Zhang X, Tong S, Wang M, Wang Z, He H, Xu H, Xiao J. Dl-3-n-butylphthalide improves functional recovery in rats with spinal cord injury by inhibiting endoplasmic reticulum stress-induced apoptosis. Am J Transl Res. 2017;9(3):1075\u201387. eCollection 2017","journal-title":"Am J Transl Res"},{"key":"3_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2021.06.003","volume":"266","author":"A Sharma","year":"2021","unstructured":"Sharma A, Muresanu DF, Patnaik R, Menon PK, Tian ZR, Sahib S, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Skaper SD, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Histamine H3 and H4 receptors modulate Parkinson\u2019s disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Prog Brain Res. 2021;266:1\u201373. https:\/\/doi.org\/10.1016\/bs.pbr.2021.06.003. Epub 2021 Oct 6","journal-title":"Prog Brain Res"},{"issue":"6","key":"3_CR191","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2217\/nmt-2016-0037","volume":"6","author":"HS Sharma","year":"2016","unstructured":"Sharma HS, Muresanu DF, Sharma A. Alzheimer\u2019s disease: cerebrolysin and nanotechnology as a therapeutic strategy. Neurodegener Dis Manag. 2016;6(6):453\u20136. https:\/\/doi.org\/10.2217\/nmt-2016-0037. Epub 2016 Nov 9","journal-title":"Neurodegener Dis Manag"},{"issue":"9","key":"3_CR192","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.2174\/1871527315666160819123059","volume":"15","author":"A Sharma","year":"2016","unstructured":"Sharma A, Menon P, Muresanu DF, Ozkizilcik A, Tian ZR, Lafuente JV, Sharma HS. Nanowired drug delivery across the blood-brain barrier in central nervous system injury and repair. Neurol Disord Drug Targets. 2016;15(9):1092\u2013117. https:\/\/doi.org\/10.2174\/1871527315666160819123059.","journal-title":"Neurol Disord Drug Targets"},{"issue":"1","key":"3_CR193","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/187152712799960736","volume":"11","author":"DF Muresanu","year":"2012","unstructured":"Muresanu DF, Sharma A, Tian ZR, Smith MA, Sharma HS. Nanowired drug delivery of antioxidant compound H-290\/51 enhances neuroprotection in hyperthermia-induced neurotoxicity. CNS Neurol Disord Drug Targets. 2012;11(1):50\u201364. https:\/\/doi.org\/10.2174\/187152712799960736.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"3_CR194","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/187152712799960727","volume":"11","author":"ZR Tian","year":"2012","unstructured":"Tian ZR, Sharma A, Nozari A, Subramaniam R, Lundstedt T, Sharma HS. Nanowired drug delivery to enhance neuroprotection in spinal cord injury. CNS Neurol Disord Drug Targets. 2012;11(1):86\u201395. https:\/\/doi.org\/10.2174\/187152712799960727.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"3_CR195","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/wnan.172","volume":"4","author":"HS Sharma","year":"2012","unstructured":"Sharma HS, Sharma A. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(2):184\u2013203. https:\/\/doi.org\/10.1002\/wnan.172. Epub 2011 Dec 8","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"5","key":"3_CR196","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00726-013-1584-z","volume":"45","author":"HS Sharma","year":"2013","unstructured":"Sharma HS, Sharma A. New perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine. Amino Acids. 2013;45(5):1055\u201371. https:\/\/doi.org\/10.1007\/s00726-013-1584-z.","journal-title":"Amino Acids"},{"key":"3_CR197","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.pbr.2019.03.008","volume":"245","author":"F Niu","year":"2019","unstructured":"Niu F, Sharma A, Feng L, Ozkizilcik A, Muresanu DF, Lafuente JV, Tian ZR, Nozari A, Sharma HS. Nanowired delivery of DL-3-n-butylphthalide induces superior neuroprotection in concussive head injury. Prog Brain Res. 2019;245:89\u2013118. https:\/\/doi.org\/10.1016\/bs.pbr.2019.03.008. Epub 2019 Apr 2","journal-title":"Prog Brain Res"},{"key":"3_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2021.04.008","volume":"265","author":"HS Sharma","year":"2021","unstructured":"Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sahib S, Tian ZR, Bryukhovetskiy I, Manzhulo I, Menon PK, Patnaik R, Wiklund L, Sharma A. Alzheimer\u2019s disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide. Prog Brain Res. 2021;265:1\u201397. https:\/\/doi.org\/10.1016\/bs.pbr.2021.04.008. Epub 2021 Aug 12","journal-title":"Prog Brain Res"},{"key":"3_CR199","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/bs.pbr.2019.03.009","volume":"245","author":"HS Sharma","year":"2019","unstructured":"Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Tian ZR, Ozkizilcik A, Manzhulo I, M\u00f6ssler H, Sharma A. Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer\u2019s disease. Prog Brain Res. 2019;245:145\u2013200. https:\/\/doi.org\/10.1016\/bs.pbr.2019.03.009. Epub 2019 Apr 2","journal-title":"Prog Brain Res"},{"key":"3_CR200","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-386986-9.00003-X","volume":"102","author":"HS Sharma","year":"2012","unstructured":"Sharma HS, Castellani RJ, Smith MA, Sharma A. The blood-brain barrier in Alzheimer\u2019s disease: novel therapeutic targets and nanodrug delivery. Int Rev Neurobiol. 2012;102:47\u201390. https:\/\/doi.org\/10.1016\/B978-0-12-386986-9.00003-X.","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"3_CR201","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41536-020-00106-y","volume":"5","author":"D Fri\u010dov\u00e1","year":"2020","unstructured":"Fri\u010dov\u00e1 D, Korchak JA, Zubair AC. Challenges and translational considerations of mesenchymal stem\/stromal cell therapy for Parkinson\u2019s disease. NPJ Regen Med. 2020;5(1):20. https:\/\/doi.org\/10.1038\/s41536-020-00106-y.","journal-title":"NPJ Regen Med"},{"issue":"7","key":"3_CR202","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2217\/epi-2019-0347","volume":"12","author":"C Thompson","year":"2020","unstructured":"Thompson C, Otero P, Srinageshwar B, Petersen RB, Dunbar GL, Rossignol J. Possible roles of epigenetics in stem cell therapy for Parkinson\u2019s disease. Epigenomics. 2020;12(7):647\u201356. https:\/\/doi.org\/10.2217\/epi-2019-0347. Epub 2020 May 12","journal-title":"Epigenomics"},{"issue":"4","key":"3_CR203","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"HX Chen","year":"2020","unstructured":"Chen HX, Liang FC, Gu P, Xu BL, Xu HJ, Wang WT, Hou JY, Xie DX, Chai XQ, An SJ. Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis. 2020;11(4):288. https:\/\/doi.org\/10.1038\/s41419-020-2473-5.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3_CR204","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3233\/JPD-191636","volume":"9","author":"R Houghton","year":"2019","unstructured":"Houghton R, Boess F, Verselis L, Ding Y, Freitas R, Constantinovici N, Ong R. Treatment patterns in patients with incident Parkinson\u2019s disease in the United States. J Parkinsons Dis. 2019;9(4):749\u201359. https:\/\/doi.org\/10.3233\/JPD-191636.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"3_CR205","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00702-020-02276-x","volume":"128","author":"S Greten","year":"2021","unstructured":"Greten S, M\u00fcller-Funogea JI, Wegner F, H\u00f6glinger GU, Simon N, Junius-Walker U, Gerbel S, Krause O, Klietz M. Drug safety profiles in geriatric patients with Parkinson\u2019s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis. J Neural Transm (Vienna). 2021;128(1):49\u201360. https:\/\/doi.org\/10.1007\/s00702-020-02276-x. Epub 2020 Dec 1","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"3_CR206","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","volume":"27","author":"T Ntetsika","year":"2021","unstructured":"Ntetsika T, Papathoma PE, Markaki I. Novel targeted therapies for Parkinson\u2019s disease. Mol Med. 2021;27(1):17. https:\/\/doi.org\/10.1186\/s10020-021-00279-2.","journal-title":"Mol Med"},{"issue":"6","key":"3_CR207","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/biom10060912","volume":"10","author":"A Polissidis","year":"2020","unstructured":"Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ. The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease. Biomol Ther. 2020;10(6):912. https:\/\/doi.org\/10.3390\/biom10060912.","journal-title":"Biomol Ther"},{"issue":"4","key":"3_CR208","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JPD-229002","volume":"12","author":"K McFarthing","year":"2022","unstructured":"McFarthing K, Rafaloff G, Baptista M, Mursaleen L, Fuest R, Wyse RK, Stott SRW. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2022 update. J Parkinsons Dis. 2022;12(4):1073\u201382. https:\/\/doi.org\/10.3233\/JPD-229002.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"3_CR209","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13287-022-03050-4","volume":"13","author":"RM Heris","year":"2022","unstructured":"Heris RM, Shirvaliloo M, Abbaspour-Aghdam S, Hazrati A, Shariati A, Youshanlouei HR, Niaragh FJ, Valizadeh H, Ahmadi M. The potential use of mesenchymal stem cells and their exosomes in Parkinson\u2019s disease treatment. Stem Cell Res Ther. 2022;13(1):371. https:\/\/doi.org\/10.1186\/s13287-022-03050-4.","journal-title":"Stem Cell Res Ther"},{"key":"3_CR210","doi-asserted-by":"publisher","unstructured":"Rufino RA, Pereira-Rufino LDS, Vissoto TCS, Kerkis I, Neves ADC, da Silva MCP. The immunomodulatory potential role of mesenchymal stem cells in diseases of the central nervous system. Neurodegener Dis. 2022; https:\/\/doi.org\/10.1159\/000528036. Online ahead of print","DOI":"10.1159\/000528036"},{"key":"3_CR211","doi-asserted-by":"publisher","first-page":"950715","DOI":"10.3389\/fneur.2022.950715","volume":"13","author":"SF Liu","year":"2022","unstructured":"Liu SF, Li LY, Zhuang JL, Li MM, Ye LC, Chen XR, Lin S, Chen CN. Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson\u2019s disease: a systematic review. Front Neurol. 2022;13:950715. https:\/\/doi.org\/10.3389\/fneur.2022.950715. eCollection 2022","journal-title":"Front Neurol"},{"key":"3_CR212","doi-asserted-by":"publisher","unstructured":"Unnisa A, Dua K, Kamal MA. Mechanism of mesenchymal stem cells as a multitarget disease-modifying therapy for parkinson\u2019s disease. Curr Neuropharmacol. 2022; https:\/\/doi.org\/10.2174\/1570159X20666220327212414. Online ahead of print","DOI":"10.2174\/1570159X20666220327212414"},{"issue":"8","key":"3_CR213","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s11011-022-01021-5","volume":"37","author":"A Asemi-Rad","year":"2022","unstructured":"Asemi-Rad A, Moafi M, Aliaghaei A, Abbaszadeh HA, Abdollahifar MA, Ebrahimi MJ, Heidari MH, Sadeghi Y. The effect of dopaminergic neuron transplantation and melatonin co-administration on oxidative stress-induced cell death in Parkinson\u2019s disease. Metab Brain Dis. 2022;37(8):2677\u201385. https:\/\/doi.org\/10.1007\/s11011-022-01021-5. Epub 2022 Sep 8","journal-title":"Metab Brain Dis"},{"key":"3_CR214","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.reth.2022.08.003","volume":"21","author":"C Ardianto","year":"2022","unstructured":"Ardianto C, Shen R, Barus JFA, Sasmita PK, Turana Y, Lilis L, Sidharta VM. Secretome as neuropathology-targeted intervention of Parkinson\u2019s disease. Regen Ther. 2022;21:288\u201393. https:\/\/doi.org\/10.1016\/j.reth.2022.08.003. eCollection 2022 Dec","journal-title":"Regen Ther"},{"issue":"1","key":"3_CR215","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/glia.20731","volume":"57","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia. 2009;57(1):13\u201323. https:\/\/doi.org\/10.1002\/glia.20731.","journal-title":"Glia"},{"issue":"7","key":"3_CR216","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2174\/1574888X16666210303151237","volume":"16","author":"LA Ahmed","year":"2021","unstructured":"Ahmed LA, Al-Massri KF. Directions for enhancement of the therapeutic efficacy of mesenchymal stem cells in different neurodegenerative and cardiovascular diseases: current status and future perspectives. Curr Stem Cell Res Ther. 2021;16(7):858\u201376. https:\/\/doi.org\/10.2174\/1574888X16666210303151237.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"3_CR217","doi-asserted-by":"publisher","first-page":"36","DOI":"10.31662\/jmaj.2021-0080","volume":"5","author":"H Yamagishi","year":"2022","unstructured":"Yamagishi H, Shigematsu K. Perspectives on stem cell-based regenerative medicine with a particular emphasis on mesenchymal stem cell therapy. JMA J. 2022;5(1):36\u201343. https:\/\/doi.org\/10.31662\/jmaj.2021-0080. Epub 2021 Dec 24","journal-title":"JMA J"},{"issue":"6","key":"3_CR218","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1007\/s12035-017-0681-5","volume":"55","author":"JA Parga","year":"2018","unstructured":"Parga JA, Garc\u00eda-Garrote M, Mart\u00ednez S, Raya \u00c1, Labandeira-Garc\u00eda JL, Rodr\u00edguez-Pallares J. Prostaglandin EP2 receptors mediate mesenchymal stromal cell-neuroprotective effects on dopaminergic neurons. Mol Neurobiol. 2018;55(6):4763\u201376. https:\/\/doi.org\/10.1007\/s12035-017-0681-5. Epub 2017 Jul 17","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3_CR219","doi-asserted-by":"publisher","first-page":"26298","DOI":"10.1038\/srep26298","volume":"27","author":"BC Lee","year":"2016","unstructured":"Lee BC, Kim HS, Shin TH, Kang I, Lee JY, Kim JJ, Kang HK, Seo Y, Lee S, Yu KR, Choi SW, Kang KS. PGE2 maintains self-renewal of human adult stem cells via EP2-mediated autocrine signaling and its production is regulated by cell-to-cell contact. Sci Rep. 2016;27(6):26298. https:\/\/doi.org\/10.1038\/srep26298.","journal-title":"Sci Rep"},{"key":"3_CR220","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/873706","volume":"2012","author":"M Kitada","year":"2012","unstructured":"Kitada M, Dezawa M. Parkinson\u2019s disease and mesenchymal stem cells: potential for cell-based therapy. Parkinsons Dis. 2012;2012:873706. https:\/\/doi.org\/10.1155\/2012\/873706. Epub 2012 Feb 28","journal-title":"Parkinsons Dis"},{"issue":"1","key":"3_CR221","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-022-00553-9","volume":"17","author":"B Xiao","year":"2022","unstructured":"Xiao B, Zhang SC, Tan EK. Combination therapy using GDNF and cell transplant in Parkinson\u2019s disease. Mol Neurodegener. 2022;17(1):49. https:\/\/doi.org\/10.1186\/s13024-022-00553-9.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"3_CR222","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2967\/jnumed.108.051896","volume":"49","author":"WC Lo","year":"2008","unstructured":"Lo WC, Hsu CH, Wu AT, Yang LY, Chen WH, Chiu WT, Lai WF, Wu CH, Gelovani JG, Deng WP. A novel cell-based therapy for contusion spinal cord injury using GDNF-delivering NIH3T3 cells with dual reporter genes monitored by molecular imaging. J Nucl Med. 2008;49(9):1512\u20139. https:\/\/doi.org\/10.2967\/jnumed.108.051896. Epub 2008 Aug 14","journal-title":"J Nucl Med"},{"issue":"5","key":"3_CR223","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12031-019-01475-w","volume":"70","author":"F Dehghanian","year":"2020","unstructured":"Dehghanian F, Soltani Z, Khaksari M. Can mesenchymal stem cells act multipotential in traumatic brain injury? J Mol Neurosci. 2020;70(5):677\u201388. https:\/\/doi.org\/10.1007\/s12031-019-01475-w. Epub 2020 Jan 2","journal-title":"J Mol Neurosci"},{"issue":"8","key":"3_CR224","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1515\/revneuro-2019-0002","volume":"30","author":"M Das","year":"2019","unstructured":"Das M, Mayilsamy K, Mohapatra SS, Mohapatra S. Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects. Rev Neurosci. 2019;30(8):839\u201355. https:\/\/doi.org\/10.1515\/revneuro-2019-0002.","journal-title":"Rev Neurosci"},{"key":"3_CR225","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fneur.2017.00028","volume":"8","author":"A Hasan","year":"2017","unstructured":"Hasan A, Deeb G, Rahal R, Atwi K, Mondello S, Marei HE, Gali A, Sleiman E. Mesenchymal stem cells in the treatment of traumatic brain injury. Front Neurol. 2017;8:28. https:\/\/doi.org\/10.3389\/fneur.2017.00028. eCollection 2017","journal-title":"Front Neurol"},{"issue":"6","key":"3_CR226","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/cns.13300","volume":"26","author":"AE Willing","year":"2020","unstructured":"Willing AE, Das M, Howell M, Mohapatra SS, Mohapatra S. Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury. CNS Neurosci Ther. 2020;26(6):616\u201327. https:\/\/doi.org\/10.1111\/cns.13300. Epub 2020 Mar 10","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"3_CR227","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/cells11091464","volume":"11","author":"A Kaminska","year":"2022","unstructured":"Kaminska A, Radoszkiewicz K, Rybkowska P, Wedzinska A, Sarnowska A. Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a promising approach in brain study and nerve regeneration. Cell. 2022;11(9):1464. https:\/\/doi.org\/10.3390\/cells11091464.","journal-title":"Cell"},{"key":"3_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113205","volume":"405","author":"HG Hamidabadi","year":"2021","unstructured":"Hamidabadi HG, Simorgh S, Kamrava SK, Namjoo Z, Bagher Z, Bojnordi MN, Niapour A, Mojaverrostami S, Saeb MR, Zarrintaj P, Olya A, Alizadeh R. Promoting motor functions in a spinal cord injury model of rats using transplantation of differentiated human olfactory stem cells: a step towards future therapy. Behav Brain Res. 2021;405:113205. https:\/\/doi.org\/10.1016\/j.bbr.2021.113205. Epub 2021 Feb 23","journal-title":"Behav Brain Res"},{"issue":"2","key":"3_CR229","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12035-007-0036-8","volume":"36","author":"AH de Haas","year":"2007","unstructured":"de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol. 2007;36(2):137\u201351. https:\/\/doi.org\/10.1007\/s12035-007-0036-8. Epub 2007 Jul 10","journal-title":"Mol Neurobiol"},{"issue":"1\u20132","key":"3_CR230","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneuroim.2008.04.012","volume":"198","author":"K Biber","year":"2008","unstructured":"Biber K, Vinet J, Boddeke HW. Neuron-microglia signaling: chemokines as versatile messengers. J Neuroimmunol. 2008;198(1\u20132):69\u201374. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.04.012. Epub 2008 Jun 5","journal-title":"J Neuroimmunol"},{"key":"3_CR231","doi-asserted-by":"publisher","first-page":"626755","DOI":"10.3389\/fimmu.2021.626755","volume":"12","author":"V Planat-Benard","year":"2021","unstructured":"Planat-Benard V, Varin A, Casteilla L. MSCs and inflammatory cells crosstalk in regenerative medicine: concerted actions for optimized resolution driven by energy metabolism. Front Immunol. 2021;12:626755. https:\/\/doi.org\/10.3389\/fimmu.2021.626755. eCollection 2021","journal-title":"Front Immunol"},{"issue":"18","key":"3_CR232","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.3390\/ijms221810045","volume":"22","author":"PT Do","year":"2021","unstructured":"Do PT, Wu CC, Chiang YH, Hu CJ, Chen KY. Mesenchymal stem\/stromal cell therapy in blood-brain barrier preservation following ischemia: molecular mechanisms and prospects. Int J Mol Sci. 2021;22(18):10045. https:\/\/doi.org\/10.3390\/ijms221810045.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"3_CR233","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.7150\/thno.34008","volume":"9","author":"Z Chen","year":"2019","unstructured":"Chen Z, Han X, Ouyang X, Fang J, Huang X, Wei H. Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury. Theranostics. 2019;9(22):6354\u201368. https:\/\/doi.org\/10.7150\/thno.34008. eCollection 2019","journal-title":"Theranostics"},{"issue":"11","key":"3_CR234","doi-asserted-by":"publisher","first-page":"20801","DOI":"10.1002\/jcp.28686","volume":"234","author":"Y Kong","year":"2019","unstructured":"Kong Y, Cheng L, Ma L, Li H, Cheng B, Zhao Y. Norepinephrine protects against apoptosis of mesenchymal stem cells induced by high glucose. J Cell Physiol. 2019;234(11):20801\u201315. https:\/\/doi.org\/10.1002\/jcp.28686. Epub 2019 Apr 29","journal-title":"J Cell Physiol"},{"issue":"3","key":"3_CR235","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/iub.1608","volume":"69","author":"EM Mohamed","year":"2017","unstructured":"Mohamed EM, Abdelrahman SA, Hussein S, Shalaby SM, Mosaad H, Awad AM. Effect of human umbilical cord blood mesenchymal stem cells administered by intravenous or intravitreal routes on cryo-induced retinal injury. IUBMB Life. 2017;69(3):188\u2013201. https:\/\/doi.org\/10.1002\/iub.1608. Epub 2017 Feb 5","journal-title":"IUBMB Life"},{"key":"3_CR236","doi-asserted-by":"publisher","first-page":"585880","DOI":"10.3389\/fimmu.2020.585880","volume":"11","author":"P Gough","year":"2020","unstructured":"Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol. 2020;11:585880. https:\/\/doi.org\/10.3389\/fimmu.2020.585880. eCollection 2020","journal-title":"Front Immunol"},{"issue":"3","key":"3_CR237","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","volume":"50","author":"HT Idriss","year":"2000","unstructured":"Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000;50(3):184\u201395. https:\/\/doi.org\/10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H.","journal-title":"Microsc Res Tech"},{"issue":"14","key":"3_CR238","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"XL Fan","year":"2020","unstructured":"Fan XL, Zhang Y, Li X, Fu QL. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77(14):2771\u201394. https:\/\/doi.org\/10.1007\/s00018-020-03454-6. Epub 2020 Jan 21","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3_CR239","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-020-01610-0","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Chen J, Cheng Y, Fu Y, Zhao H, Tang M, Zhao H, Lin N, Shi X, Lei Y, Wang S, Huang L, Wu W, Tan J. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation. Stem Cell Res Ther. 2020;11(1):97. https:\/\/doi.org\/10.1186\/s13287-020-01610-0.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3_CR240","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/stem.2310","volume":"34","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Gibb SL, Zhao J, Moore AN, Hylin MJ, Menge T, Xue H, Baimukanova G, Potter D, Johnson EM, Holcomb JB, Cox CS Jr, Dash PK, Pati S. Wnt3a, a protein secreted by mesenchymal stem cells is neuroprotective and promotes neurocognitive recovery following traumatic brain injury. Stem Cells. 2016;34(5):1263\u201372. https:\/\/doi.org\/10.1002\/stem.2310.","journal-title":"Stem Cells"},{"issue":"7","key":"3_CR241","doi-asserted-by":"publisher","first-page":"2002944","DOI":"10.1002\/advs.202002944","volume":"8","author":"A Andrzejewska","year":"2021","unstructured":"Andrzejewska A, Dabrowska S, Lukomska B, Janowski M. Mesenchymal stem cells for neurological disorders. Adv Sci (Weinh). 2021;8(7):2002944. https:\/\/doi.org\/10.1002\/advs.202002944. eCollection 2021 Apr","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"3_CR242","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3390\/ijms20112698","volume":"20","author":"F Cofano","year":"2019","unstructured":"Cofano F, Boido M, Monticelli M, Zenga F, Ducati A, Vercelli A, Garbossa D. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci. 2019;20(11):2698. https:\/\/doi.org\/10.3390\/ijms20112698.","journal-title":"Int J Mol Sci"},{"key":"3_CR243","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2014.05.029","volume":"1573","author":"DG Phinney","year":"2014","unstructured":"Phinney DG, Isakova IA. Mesenchymal stem cells as cellular vectors for pediatric neurological disorders. Brain Res. 2014;1573:92\u2013107. https:\/\/doi.org\/10.1016\/j.brainres.2014.05.029. Epub 2014 May 22","journal-title":"Brain Res"},{"key":"3_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118020","volume":"257","author":"M Amidfar","year":"2020","unstructured":"Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK. The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease. Life Sci. 2020;257:118020. https:\/\/doi.org\/10.1016\/j.lfs.2020.118020. Epub 2020 Jun 27","journal-title":"Life Sci"},{"issue":"1","key":"3_CR245","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13287-019-1419-2","volume":"10","author":"J Fang","year":"2019","unstructured":"Fang J, Zhao X, Li S, Xing X, Wang H, Lazarovici P, Zheng W. Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1\/2-p90rsk-CREB pathway. Stem Cell Res Ther. 2019;10(1):312. https:\/\/doi.org\/10.1186\/s13287-019-1419-2.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"3_CR246","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/cbin.11687","volume":"45","author":"B Chen","year":"2021","unstructured":"Chen B, An J, Guo YS, Tang J, Zhao JJ, Zhang R, Yang H. Tetramethylpyrazine induces the release of BDNF from BM-MSCs through activation of the PI3K\/AKT\/CREB pathway. Cell Biol Int. 2021;45(12):2429\u201342. https:\/\/doi.org\/10.1002\/cbin.11687. Epub 2021 Aug 23","journal-title":"Cell Biol Int"},{"issue":"10","key":"3_CR247","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/sj.jcbfm.9600475","volume":"27","author":"A Zacharek","year":"2007","unstructured":"Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M. Angiopoietin1\/Tie2 and VEGF\/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab. 2007;27(10):1684\u201391. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600475. Epub 2007 Mar 14","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"3_CR248","doi-asserted-by":"publisher","first-page":"C1021","DOI":"10.1152\/ajpcell.00191.2012","volume":"303","author":"M Mastri","year":"2012","unstructured":"Mastri M, Shah Z, McLaughlin T, Greene CJ, Baum L, Suzuki G, Lee T. Activation of toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. Am J Physiol Cell Physiol. 2012;303(10):C1021\u201333. https:\/\/doi.org\/10.1152\/ajpcell.00191.2012. Epub 2012 Jul 25","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"3_CR249","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/cells9051157","volume":"9","author":"DH Ha","year":"2020","unstructured":"Ha DH, Kim HK, Lee J, Kwon HH, Park GH, Yang SH, Jung JY, Choi H, Lee JH, Sung S, Yi YW, Cho BS. Mesenchymal stem\/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration. Cell. 2020;9(5):1157. https:\/\/doi.org\/10.3390\/cells9051157.","journal-title":"Cell"},{"issue":"1","key":"3_CR250","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s13287-021-02629-7","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Liu G, Zhang K, Cao Q, Liu T, Li J. Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Res Ther. 2021;12(1):561. https:\/\/doi.org\/10.1186\/s13287-021-02629-7.","journal-title":"Stem Cell Res Ther"},{"key":"3_CR251","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/bs.pbr.2020.09.010","volume":"258","author":"A Sharma","year":"2020","unstructured":"Sharma A, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Sahib S, Tian ZR, Buzoianu AD, Patnaik R, Wiklund L, Sharma HS. Mild traumatic brain injury exacerbates Parkinson\u2019s disease induced hemeoxygenase-2 expression and brain pathology: neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin. Prog Brain Res. 2020;258:157\u2013231. https:\/\/doi.org\/10.1016\/bs.pbr.2020.09.010. Epub 2020 Nov 9","journal-title":"Prog Brain Res"},{"issue":"2","key":"3_CR252","first-page":"147","volume":"4","author":"AC Wilson","year":"2011","unstructured":"Wilson AC, Dugger BN, Dickson DW, Wang DS. TDP-43 in aging and Alzheimer\u2019s disease \u2013 a review. Int J Clin Exp Pathol. 2011;4(2):147\u201355. PMID: 21326809 Free PMC article. Review","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"3_CR253","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s12035-022-02847-x","volume":"59","author":"YZ Liao","year":"2022","unstructured":"Liao YZ, Ma J, Dou JZ. The role of TDP-43 in neurodegenerative disease. Mol Neurobiol. 2022;59(7):4223\u201341. https:\/\/doi.org\/10.1007\/s12035-022-02847-x. Epub 2022 May 2","journal-title":"Mol Neurobiol"},{"key":"3_CR254","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0079-6123(06)62013-X","volume":"162","author":"HS Sharma","year":"2007","unstructured":"Sharma HS, Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog Brain Res. 2007;162:245\u201373. https:\/\/doi.org\/10.1016\/S0079-6123(06)62013-X.","journal-title":"Prog Brain Res"},{"key":"3_CR255","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/bs.pbr.2021.06.015","volume":"265","author":"A Sharma","year":"2021","unstructured":"Sharma A, Feng L, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Wiklund L, Sharma HS. Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions. Prog Brain Res. 2021;265:385\u2013406. https:\/\/doi.org\/10.1016\/bs.pbr.2021.06.015. Epub 2021 Aug 13","journal-title":"Prog Brain Res"},{"key":"3_CR256","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/bs.pbr.2021.06.013","volume":"266","author":"A Sharma","year":"2021","unstructured":"Sharma A, Feng L, Muresanu DF, Huang H, Menon PK, Sahib S, Ryan Tian Z, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Wiklund L, Sharma HS. Topical application of CNTF, GDNF and BDNF in combination attenuates blood-spinal cord barrier permeability, edema formation, hemeoxygenase-2 upregulation, and cord pathology. Prog Brain Res. 2021;266:357\u201376. https:\/\/doi.org\/10.1016\/bs.pbr.2021.06.013. Epub 2021 Jul 15","journal-title":"Prog Brain Res"},{"key":"3_CR257","doi-asserted-by":"publisher","unstructured":"Sharma HS, Feng L, Chen L, Huang H, Ryan Tian Z, Nozari A, Muresanu DF, Lafuente JV, Castellani RJ, Wiklund L, Sharma A. Cerebrolysin attenuates exacerbation of neuropathic pain, blood-spinal cord barrier breakdown and cord pathology following chronic intoxication of engineered ag, cu or Al (50\u201360 nm) nanoparticles. Neurochem Res. 2023; https:\/\/doi.org\/10.1007\/s11064-023-03861-8. Online ahead of print","DOI":"10.1007\/s11064-023-03861-8"},{"issue":"3","key":"3_CR258","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2174\/1871527314666150318114335","volume":"14","author":"HS Sharma","year":"2015","unstructured":"Sharma HS, Feng L, Lafuente JV, Muresanu DF, Tian ZR, Patnaik R, Sharma A. TiO2-nanowired delivery of mesenchymal stem cells thwarts diabetes- induced exacerbation of brain pathology in heat stroke: An experimental study in the rat using morphological and biochemical approaches. CNS Neurol Disord Drug Targets. 2015;14(3):386\u201399. https:\/\/doi.org\/10.2174\/1871527314666150318114335.","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Advances in Neurobiology","Progress in Nanomedicine in Neurologic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-32997-5_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T14:01:54Z","timestamp":1690034514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-32997-5_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031329968","9783031329975"],"references-count":258,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-32997-5_3","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"23 July 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}